graveoline: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 353825 |
| CHEMBL ID | 1371756 |
| CHEBI ID | 5541 |
| MeSH ID | M0468704 |
| Synonym |
|---|
| BRD-K92683369-001-03-6 |
| alkaloid from ruta angustifolia plant |
| nsc-603064 |
| graveolin |
| NSC603064 , |
| MLS001048950 |
| smr000386974 |
| PRESTWICK_165 |
| cas-485-61-0 |
| NCGC00016465-01 |
| BSPBIO_000767 |
| PRESTWICK3_000674 |
| NCGC00179443-01 |
| OPREA1_746980 |
| PRESTWICK2_000674 |
| BPBIO1_000845 |
| 485-61-0 |
| graveoline |
| PRESTWICK0_000674 |
| PRESTWICK1_000674 |
| SPBIO_002688 |
| 2-(1,3-benzodioxol-5-yl)-1-methylquinolin-4-one |
| AKOS002141814 |
| HMS1570G09 |
| HMS2097G09 |
| chebi:5541 , |
| CHEMBL1371756 |
| HMS2268L04 |
| NCGC00016465-02 |
| CCG-208356 |
| 2-(1,3-benzodioxol-5-yl)-1-methyl-4(1h)-quinolinone (graveoline) |
| COBBNRKBTCBWQP-UHFFFAOYSA-N |
| DTXSID80326593 |
| 2-(2h-1,3-benzodioxol-5-yl)-1-methyl-1,4-dihydroquinolin-4-one |
| 4(1h)-quinolinone, 2-(1,3-benzodioxol-5-yl)-1-methyl- |
| SR-01000737557-3 |
| sr-01000737557 |
| 2-(1,3-benzodioxol-5-yl)-1-methyl-4(1h)-quinolinone, 9ci |
| 1-methyl-2-(3,4-methylenedioxyphenyl)-4(1h)-quinolinone |
| rutamine |
| foliosine |
| 2-(benzo[d][1,3]dioxol-5-yl)-1-methylquinolin-4(1h)-one |
| graveoline (4-chinolon) |
| ZB1720 |
| DS-19520 |
| Q27106801 |
| STL565967 |
| 2-(1,3-benzodioxol-5-yl)-1-methylquinolin-4(1h)-one |
| C75292 |
| SB71513 |
| CS-0011994 |
| Excerpt | Reference |
|---|---|
| "Graveoline is a biologically active ingredient extracted from Ruta graveolens. " | ( Guo, S; Liu, H; Xi, S, 2023) |
| Class | Description |
|---|---|
| quinolines | A class of aromatic heterocyclic compounds each of which contains a benzene ring ortho fused to carbons 2 and 3 of a pyridine ring. |
| [compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] | |
| Protein | Taxonomy | Measurement | Average (µ) | Min (ref.) | Avg (ref.) | Max (ref.) | Bioassay(s) |
|---|---|---|---|---|---|---|---|
| Chain A, HADH2 protein | Homo sapiens (human) | Potency | 12.5893 | 0.0251 | 20.2376 | 39.8107 | AID893 |
| Chain B, HADH2 protein | Homo sapiens (human) | Potency | 12.5893 | 0.0251 | 20.2376 | 39.8107 | AID893 |
| Chain A, 2-oxoglutarate Oxygenase | Homo sapiens (human) | Potency | 22.1061 | 0.1778 | 14.3909 | 39.8107 | AID2147 |
| Chain A, Ferritin light chain | Equus caballus (horse) | Potency | 11.2202 | 5.6234 | 17.2929 | 31.6228 | AID485281 |
| glp-1 receptor, partial | Homo sapiens (human) | Potency | 3.5481 | 0.0184 | 6.8060 | 14.1254 | AID624417 |
| aldehyde dehydrogenase 1 family, member A1 | Homo sapiens (human) | Potency | 27.8298 | 0.0112 | 12.4002 | 100.0000 | AID1030 |
| hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | Homo sapiens (human) | Potency | 7.9433 | 0.0013 | 7.7625 | 44.6684 | AID914; AID915 |
| cytochrome P450 2D6 isoform 1 | Homo sapiens (human) | Potency | 1.5849 | 0.0020 | 7.5337 | 39.8107 | AID891 |
| cytochrome P450 2C19 precursor | Homo sapiens (human) | Potency | 1.9953 | 0.0025 | 5.8400 | 31.6228 | AID899 |
| 15-hydroxyprostaglandin dehydrogenase [NAD(+)] isoform 1 | Homo sapiens (human) | Potency | 11.2202 | 0.0018 | 15.6638 | 39.8107 | AID894 |
| parathyroid hormone/parathyroid hormone-related peptide receptor precursor | Homo sapiens (human) | Potency | 100.0000 | 3.5481 | 19.5427 | 44.6684 | AID743266 |
| cytochrome P450 3A4 isoform 1 | Homo sapiens (human) | Potency | 10.0000 | 0.0316 | 10.2792 | 39.8107 | AID884; AID885 |
| lamin isoform A-delta10 | Homo sapiens (human) | Potency | 3.1623 | 0.8913 | 12.0676 | 28.1838 | AID1487 |
| Gamma-aminobutyric acid receptor subunit pi | Rattus norvegicus (Norway rat) | Potency | 10.0000 | 1.0000 | 12.2248 | 31.6228 | AID885 |
| Gamma-aminobutyric acid receptor subunit beta-1 | Rattus norvegicus (Norway rat) | Potency | 10.0000 | 1.0000 | 12.2248 | 31.6228 | AID885 |
| Gamma-aminobutyric acid receptor subunit delta | Rattus norvegicus (Norway rat) | Potency | 10.0000 | 1.0000 | 12.2248 | 31.6228 | AID885 |
| Gamma-aminobutyric acid receptor subunit gamma-2 | Rattus norvegicus (Norway rat) | Potency | 10.0000 | 1.0000 | 12.2248 | 31.6228 | AID885 |
| Gamma-aminobutyric acid receptor subunit alpha-5 | Rattus norvegicus (Norway rat) | Potency | 10.0000 | 1.0000 | 12.2248 | 31.6228 | AID885 |
| Gamma-aminobutyric acid receptor subunit alpha-3 | Rattus norvegicus (Norway rat) | Potency | 10.0000 | 1.0000 | 12.2248 | 31.6228 | AID885 |
| Gamma-aminobutyric acid receptor subunit gamma-1 | Rattus norvegicus (Norway rat) | Potency | 10.0000 | 1.0000 | 12.2248 | 31.6228 | AID885 |
| Gamma-aminobutyric acid receptor subunit alpha-2 | Rattus norvegicus (Norway rat) | Potency | 10.0000 | 1.0000 | 12.2248 | 31.6228 | AID885 |
| Gamma-aminobutyric acid receptor subunit alpha-4 | Rattus norvegicus (Norway rat) | Potency | 10.0000 | 1.0000 | 12.2248 | 31.6228 | AID885 |
| Gamma-aminobutyric acid receptor subunit gamma-3 | Rattus norvegicus (Norway rat) | Potency | 10.0000 | 1.0000 | 12.2248 | 31.6228 | AID885 |
| Gamma-aminobutyric acid receptor subunit alpha-6 | Rattus norvegicus (Norway rat) | Potency | 10.0000 | 1.0000 | 12.2248 | 31.6228 | AID885 |
| Gamma-aminobutyric acid receptor subunit alpha-1 | Rattus norvegicus (Norway rat) | Potency | 10.0000 | 1.0000 | 12.2248 | 31.6228 | AID885 |
| Gamma-aminobutyric acid receptor subunit beta-3 | Rattus norvegicus (Norway rat) | Potency | 10.0000 | 1.0000 | 12.2248 | 31.6228 | AID885 |
| Gamma-aminobutyric acid receptor subunit beta-2 | Rattus norvegicus (Norway rat) | Potency | 10.0000 | 1.0000 | 12.2248 | 31.6228 | AID885 |
| Rap guanine nucleotide exchange factor 4 | Homo sapiens (human) | Potency | 3.1623 | 3.9811 | 46.7448 | 112.2020 | AID720708 |
| GABA theta subunit | Rattus norvegicus (Norway rat) | Potency | 10.0000 | 1.0000 | 12.2248 | 31.6228 | AID885 |
| Gamma-aminobutyric acid receptor subunit epsilon | Rattus norvegicus (Norway rat) | Potency | 10.0000 | 1.0000 | 12.2248 | 31.6228 | AID885 |
| [prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] | |||||||
| Process | via Protein(s) | Taxonomy |
|---|---|---|
| guanyl-nucleotide exchange factor activity | Rap guanine nucleotide exchange factor 4 | Homo sapiens (human) |
| protein binding | Rap guanine nucleotide exchange factor 4 | Homo sapiens (human) |
| cAMP binding | Rap guanine nucleotide exchange factor 4 | Homo sapiens (human) |
| protein-macromolecule adaptor activity | Rap guanine nucleotide exchange factor 4 | Homo sapiens (human) |
| small GTPase binding | Rap guanine nucleotide exchange factor 4 | Homo sapiens (human) |
| [Information is prepared from geneontology information from the June-17-2024 release] | ||
| Process | via Protein(s) | Taxonomy |
|---|---|---|
| plasma membrane | Gamma-aminobutyric acid receptor subunit gamma-2 | Rattus norvegicus (Norway rat) |
| plasma membrane | Gamma-aminobutyric acid receptor subunit alpha-1 | Rattus norvegicus (Norway rat) |
| plasma membrane | Gamma-aminobutyric acid receptor subunit beta-2 | Rattus norvegicus (Norway rat) |
| cytosol | Rap guanine nucleotide exchange factor 4 | Homo sapiens (human) |
| plasma membrane | Rap guanine nucleotide exchange factor 4 | Homo sapiens (human) |
| membrane | Rap guanine nucleotide exchange factor 4 | Homo sapiens (human) |
| hippocampal mossy fiber to CA3 synapse | Rap guanine nucleotide exchange factor 4 | Homo sapiens (human) |
| plasma membrane | Rap guanine nucleotide exchange factor 4 | Homo sapiens (human) |
| [Information is prepared from geneontology information from the June-17-2024 release] | ||
| Assay ID | Title | Year | Journal | Article |
|---|---|---|---|---|
| AID651635 | Viability Counterscreen for Primary qHTS for Inhibitors of ATXN expression | |||
| AID588499 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set | 2010 | Current protocols in cytometry, Oct, Volume: Chapter 13 | Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening. |
| AID588499 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set | 2006 | Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5 | Microsphere-based protease assays and screening application for lethal factor and factor Xa. |
| AID588499 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set | 2010 | Assay and drug development technologies, Feb, Volume: 8, Issue:1 | High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors. |
| AID588497 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set | 2010 | Current protocols in cytometry, Oct, Volume: Chapter 13 | Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening. |
| AID588497 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set | 2006 | Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5 | Microsphere-based protease assays and screening application for lethal factor and factor Xa. |
| AID588497 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set | 2010 | Assay and drug development technologies, Feb, Volume: 8, Issue:1 | High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors. |
| AID588501 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set | 2010 | Current protocols in cytometry, Oct, Volume: Chapter 13 | Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening. |
| AID588501 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set | 2006 | Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5 | Microsphere-based protease assays and screening application for lethal factor and factor Xa. |
| AID588501 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set | 2010 | Assay and drug development technologies, Feb, Volume: 8, Issue:1 | High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors. |
| AID504812 | Inverse Agonists of the Thyroid Stimulating Hormone Receptor: HTS campaign | 2010 | Endocrinology, Jul, Volume: 151, Issue:7 | A small molecule inverse agonist for the human thyroid-stimulating hormone receptor. |
| AID1745845 | Primary qHTS for Inhibitors of ATXN expression | |||
| AID504810 | Antagonists of the Thyroid Stimulating Hormone Receptor: HTS campaign | 2010 | Endocrinology, Jul, Volume: 151, Issue:7 | A small molecule inverse agonist for the human thyroid-stimulating hormone receptor. |
| AID540299 | A screen for compounds that inhibit the MenB enzyme of Mycobacterium tuberculosis | 2010 | Bioorganic & medicinal chemistry letters, Nov-01, Volume: 20, Issue:21 | Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis. |
| AID588519 | A screen for compounds that inhibit viral RNA polymerase binding and polymerization activities | 2011 | Antiviral research, Sep, Volume: 91, Issue:3 | High-throughput screening identification of poliovirus RNA-dependent RNA polymerase inhibitors. |
| AID697852 | Inhibition of electric eel AChE at 2 mg/ml by Ellman's method | 2012 | Bioorganic & medicinal chemistry, Nov-15, Volume: 20, Issue:22 | Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine. |
| AID1103220 | Phytotoxicity against Lactuca sativa cv. Burpee's Iceberg (lettuce) assessed as cellular leakage at 100 uM measured after incubation over 18 hr in darkness and 24 hr in light by spectrophotometry relative to control | 2004 | Journal of agricultural and food chemistry, Jun-02, Volume: 52, Issue:11 | Phytotoxins from the leaves of Ruta graveolens. |
| AID1503775 | Antichlamydial activity against Chlamydia pneumoniae K7 infected in HL cells assessed as chlamydial inhibition at 50 uM after 70 hrs by fluorescent microscopic analysis | 2017 | Journal of natural products, 10-27, Volume: 80, Issue:10 | Identification of Privileged Antichlamydial Natural Products by a Ligand-Based Strategy. |
| AID1102095 | Stimulation of Diaporthe ampelina growth at 30 to 300 uM after 120 hr by microplate photometric analysis | 2003 | Journal of agricultural and food chemistry, Feb-12, Volume: 51, Issue:4 | Natural fungicides from Ruta graveolens L. leaves, including a new quinolone alkaloid. |
| AID697853 | Inhibition of horse BChE at 2 mg/ml by Ellman's method | 2012 | Bioorganic & medicinal chemistry, Nov-15, Volume: 20, Issue:22 | Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine. |
| AID1103224 | Phytotoxicity against Lactuca sativa cv. Burpee's Iceberg (lettuce) assessed as reduction in chlorophyll content compound treated at 100 uM in darkness after 7 days followed by exposure to white light by spectrophotometry | 2004 | Journal of agricultural and food chemistry, Jun-02, Volume: 52, Issue:11 | Phytotoxins from the leaves of Ruta graveolens. |
| AID1102101 | Antifungal activity against Phomopsis obscurans assessed as growth inhibition at 100 uM after 120 hr by microplate photometric analysis | 2003 | Journal of agricultural and food chemistry, Feb-12, Volume: 51, Issue:4 | Natural fungicides from Ruta graveolens L. leaves, including a new quinolone alkaloid. |
| AID1103225 | Phytotoxicity against Lactuca sativa cv. Burpee's Iceberg (lettuce) assessed as reduction in chlorophyll content at 100 uM after 7 days by spectrophotometry | 2004 | Journal of agricultural and food chemistry, Jun-02, Volume: 52, Issue:11 | Phytotoxins from the leaves of Ruta graveolens. |
| AID1102115 | Antifungal activity against Colletotrichum fragariae assessed as growth inhibition at 30 to 300 uM after 48 hr by microplate photometric analysis | 2003 | Journal of agricultural and food chemistry, Feb-12, Volume: 51, Issue:4 | Natural fungicides from Ruta graveolens L. leaves, including a new quinolone alkaloid. |
| AID1503774 | Cytotoxicity against human HL cells assessed as cell viability at 50 uM after 72 hrs by resazurin dye based fluorescence assay relative to control | 2017 | Journal of natural products, 10-27, Volume: 80, Issue:10 | Identification of Privileged Antichlamydial Natural Products by a Ligand-Based Strategy. |
| AID1102109 | Antifungal activity against Fusarium oxysporum assessed as growth inhibition at 300 uM after 48 hr by microplate photometric analysis | 2003 | Journal of agricultural and food chemistry, Feb-12, Volume: 51, Issue:4 | Natural fungicides from Ruta graveolens L. leaves, including a new quinolone alkaloid. |
| AID1103219 | Phytotoxicity against Agrostis stolonifera assessed as mortality at 333 uM after 12 days | 2004 | Journal of agricultural and food chemistry, Jun-02, Volume: 52, Issue:11 | Phytotoxins from the leaves of Ruta graveolens. |
| AID1103216 | Phytotoxicity against Allium cepa (onion) assessed as inhibition of mitosis in root tips at 100 uM measured on day 7 of compound treatment by microscopy | 2004 | Journal of agricultural and food chemistry, Jun-02, Volume: 52, Issue:11 | Phytotoxins from the leaves of Ruta graveolens. |
| AID1102104 | Stimulation of Botryotinia fuckeliana growth at 30 uM after 48 hr by microplate photometric analysis | 2003 | Journal of agricultural and food chemistry, Feb-12, Volume: 51, Issue:4 | Natural fungicides from Ruta graveolens L. leaves, including a new quinolone alkaloid. |
| AID1103218 | Phytotoxicity against Lemna paucicostata assessed as growth inhibition at 100 uM after 4 to 5 days | 2004 | Journal of agricultural and food chemistry, Jun-02, Volume: 52, Issue:11 | Phytotoxins from the leaves of Ruta graveolens. |
| AID1103217 | Phytotoxicity against Lemna paucicostata assessed as tissue degradation at 250 uM after 4 to 5 days | 2004 | Journal of agricultural and food chemistry, Jun-02, Volume: 52, Issue:11 | Phytotoxins from the leaves of Ruta graveolens. |
| AID1159607 | Screen for inhibitors of RMI FANCM (MM2) intereaction | 2016 | Journal of biomolecular screening, Jul, Volume: 21, Issue:6 | A High-Throughput Screening Strategy to Identify Protein-Protein Interaction Inhibitors That Block the Fanconi Anemia DNA Repair Pathway. |
| [information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||||
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (13.64) | 29.6817 |
| 2010's | 13 (59.09) | 24.3611 |
| 2020's | 6 (27.27) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 1 (4.55%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 21 (95.45%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
| Substance | Description | Relationhip Strength | Studies | Trials | Classes | Roles |
|---|---|---|---|---|---|---|
| 5-methoxypsoralen | [no description available] | medium | 4 | 0 | 5-methoxyfurocoumarin; organic heterotricyclic compound; psoralens | hepatoprotective agent; plant metabolite |
| methoxsalen | [no description available] | medium | 13 | 0 | aromatic ether; psoralens | antineoplastic agent; cross-linking reagent; dermatologic drug; photosensitizing agent; plant metabolite |
| captan | [no description available] | medium | 1 | 0 | isoindoles; organochlorine compound; organosulfur compound; phthalimide fungicide | antifungal agrochemical |
| kokusaginine | [no description available] | medium | 1 | 0 | organic heterotricyclic compound; organonitrogen heterocyclic compound; oxacycle | |
| herniarin | [no description available] | medium | 1 | 0 | coumarins | fluorochrome |
| benomyl | [no description available] | medium | 1 | 0 | aromatic amide; benzimidazole fungicide; benzimidazoles; benzimidazolylcarbamate fungicide; carbamate ester | acaricide; anthelminthic drug; antifungal agrochemical; microtubule-destabilising agent; tubulin modulator |
| 7-hydroxycoumarin | [no description available] | medium | 1 | 0 | hydroxycoumarin | fluorescent probe; food component; plant metabolite |
| pseudane ix | [no description available] | medium | 1 | 0 | ||
| 4-hydroxycoumarin | [no description available] | medium | 1 | 0 | hydroxycoumarin | |
| 4-aminophenol | [no description available] | medium | 1 | 0 | aminophenol | allergen; metabolite |
| indoleacetic acid | [no description available] | medium | 1 | 0 | indole-3-acetic acids; monocarboxylic acid | auxin; human metabolite; mouse metabolite; plant hormone; plant metabolite |
| melatonin | [no description available] | medium | 1 | 0 | acetamides; tryptamines | anticonvulsant; central nervous system depressant; geroprotector; hormone; human metabolite; immunological adjuvant; mouse metabolite; radical scavenger |
| epibatidine | [no description available] | medium | 1 | 0 | alkaloid | |
| aristolochic acid i | [no description available] | medium | 1 | 0 | aristolochic acids; aromatic ether; C-nitro compound; cyclic acetal; monocarboxylic acid; organic heterotetracyclic compound | carcinogenic agent; metabolite; mutagen; nephrotoxin; toxin |
| 2,3-dimethoxy-5-methyl-6-decyl-1,4-benzoquinone | [no description available] | medium | 1 | 0 | 1,4-benzoquinones | cofactor |
| 3,3'-diindolylmethane | [no description available] | medium | 1 | 0 | indoles | antineoplastic agent; P450 inhibitor |
| ellipticine | [no description available] | medium | 1 | 0 | indole alkaloid; organic heterotetracyclic compound; organonitrogen heterocyclic compound; polycyclic heteroarene | antineoplastic agent; plant metabolite |
| embelin | [no description available] | medium | 1 | 0 | dihydroxy-1,4-benzoquinones | antimicrobial agent; antineoplastic agent; hepatitis C protease inhibitor; plant metabolite |
| emodin | [no description available] | medium | 1 | 0 | trihydroxyanthraquinone | antineoplastic agent; laxative; plant metabolite; tyrosine kinase inhibitor |
| gossypol | [no description available] | medium | 2 | 0 | ||
| hypericin | [no description available] | medium | 1 | 0 | ||
| indole-3-carbinol | [no description available] | medium | 1 | 0 | indolyl alcohol | antineoplastic agent; plant metabolite |
| nsc 664704 | [no description available] | medium | 1 | 0 | indolobenzazepine; lactam; organobromine compound | cardioprotective agent; EC 2.7.11.22 (cyclin-dependent kinase) inhibitor; EC 2.7.11.26 (tau-protein kinase) inhibitor; geroprotector |
| khellin | [no description available] | medium | 1 | 0 | furanochromone; organic heterotricyclic compound; oxacycle | anti-asthmatic agent; bronchodilator agent; cardiovascular drug; vasodilator agent |
| kinetin | [no description available] | medium | 1 | 0 | 6-aminopurines; furans | cytokinin; geroprotector |
| beta-lapachone | [no description available] | medium | 1 | 0 | benzochromenone; orthoquinones | anti-inflammatory agent; antineoplastic agent; plant metabolite |
| lavendustin a | [no description available] | medium | 1 | 0 | aromatic amine | |
| lavendustin b | [no description available] | medium | 1 | 0 | ||
| vitamin k 3 | [no description available] | medium | 1 | 0 | 1,4-naphthoquinones; vitamin K | angiogenesis inhibitor; antineoplastic agent; EC 3.4.22.69 (SARS coronavirus main proteinase) inhibitor; human urinary metabolite; nutraceutical |
| myristicin | [no description available] | medium | 1 | 0 | organic molecular entity | metabolite |
| nalidixic acid | [no description available] | medium | 2 | 0 | 1,8-naphthyridine derivative; monocarboxylic acid; quinolone antibiotic | antibacterial drug; antimicrobial agent; DNA synthesis inhibitor |
| 6,7-dimethoxy-3-(4-methoxy-6-methyl-7,8-dihydro-5H-[1,3]dioxolo[4,5-g]isoquinolin-5-yl)-3H-isobenzofuran-1-one | [no description available] | medium | 1 | 0 | isoquinolines | |
| patulin | [no description available] | medium | 1 | 0 | furopyran; gamma-lactone; lactol | antimicrobial agent; Aspergillus metabolite; carcinogenic agent; mutagen; mycotoxin; Penicillium metabolite |
| phloretin | [no description available] | medium | 1 | 0 | dihydrochalcones | antineoplastic agent; plant metabolite |
| sanguinarine | [no description available] | medium | 1 | 0 | alkaloid antibiotic; benzophenanthridine alkaloid; botanical anti-fungal agent | |
| streptonigrin | [no description available] | medium | 1 | 0 | pyridines; quinolone | antimicrobial agent; antineoplastic agent |
| tetrahydropapaverine | [no description available] | medium | 1 | 0 | aromatic ether; benzylisoquinoline alkaloid; benzyltetrahydroisoquinoline; polyether; secondary amino compound | |
| theobromine | [no description available] | medium | 1 | 0 | dimethylxanthine | adenosine receptor antagonist; bronchodilator agent; food component; human blood serum metabolite; mouse metabolite; plant metabolite; vasodilator agent |
| trioxsalen | [no description available] | medium | 1 | 0 | psoralens | dermatologic drug; photosensitizing agent |
| mitomycin | [no description available] | medium | 1 | 0 | mitomycin | alkylating agent; antineoplastic agent |
| reserpine | [no description available] | medium | 1 | 0 | alkaloid ester; methyl ester; yohimban alkaloid | adrenergic uptake inhibitor; antihypertensive agent; EC 3.4.21.26 (prolyl oligopeptidase) inhibitor; environmental contaminant; first generation antipsychotic; plant metabolite; xenobiotic |
| pilocarpine hydrochloride | [no description available] | medium | 1 | 0 | hydrochloride | |
| cantharidin | [no description available] | medium | 1 | 0 | cyclic dicarboxylic anhydride; monoterpenoid | EC 3.1.3.16 (phosphoprotein phosphatase) inhibitor; herbicide |
| physostigmine | [no description available] | medium | 1 | 0 | carbamate ester; indole alkaloid | antidote to curare poisoning; EC 3.1.1.8 (cholinesterase) inhibitor; miotic |
| kanamycin a | [no description available] | medium | 1 | 0 | kanamycins | bacterial metabolite |
| veratramine | [no description available] | medium | 1 | 0 | piperidine alkaloid | |
| phlorhizin | [no description available] | medium | 1 | 0 | aryl beta-D-glucoside; dihydrochalcones; monosaccharide derivative | antioxidant; plant metabolite |
| papaverine hydrochloride | [no description available] | medium | 1 | 0 | ||
| colchicine | [no description available] | medium | 1 | 0 | alkaloid; colchicine | anti-inflammatory agent; gout suppressant; mutagen |
| yohimbine hydrochloride | [no description available] | medium | 1 | 0 | ||
| cycloheximide | [no description available] | medium | 2 | 0 | antibiotic fungicide; cyclic ketone; dicarboximide; piperidine antibiotic; piperidones; secondary alcohol | anticoronaviral agent; bacterial metabolite; ferroptosis inhibitor; neuroprotective agent; protein synthesis inhibitor |
| gliotoxin | [no description available] | medium | 1 | 0 | dipeptide; organic disulfide; organic heterotetracyclic compound; pyrazinoindole | antifungal agent; EC 2.5.1.58 (protein farnesyltransferase) inhibitor; immunosuppressive agent; mycotoxin; proteasome inhibitor |
| tubercidin | [no description available] | medium | 1 | 0 | antibiotic antifungal agent; N-glycosylpyrrolopyrimidine; ribonucleoside | antimetabolite; antineoplastic agent; bacterial metabolite |
| veratridine | [no description available] | medium | 1 | 0 | steroid | sodium channel modulator |
| gibberellic acid | [no description available] | medium | 1 | 0 | C19-gibberellin; gibberellin monocarboxylic acid; lactone; organic heteropentacyclic compound | mouse metabolite; plant metabolite |
| visnagin | [no description available] | medium | 1 | 0 | aromatic ether; furanochromone; polyketide | anti-inflammatory agent; antihypertensive agent; EC 1.1.1.37 (malate dehydrogenase) inhibitor; phytotoxin; plant metabolite; vasodilator agent |
| rotenone | [no description available] | medium | 1 | 0 | organic heteropentacyclic compound; rotenones | antineoplastic agent; metabolite; mitochondrial NADH:ubiquinone reductase inhibitor; phytogenic insecticide; piscicide; toxin |
| skimmianine | [no description available] | medium | 1 | 0 | alkaloid antibiotic; organic heterotricyclic compound; organonitrogen heterocyclic compound; oxacycle | |
| syrosingopine | [no description available] | medium | 1 | 0 | yohimban alkaloid | |
| gramine | [no description available] | medium | 1 | 0 | aminoalkylindole; indole alkaloid; tertiary amino compound | antibacterial agent; antiviral agent; plant metabolite; serotonergic antagonist |
| methylergonovine | [no description available] | medium | 1 | 0 | ergoline alkaloid | |
| 2,2'-methylenebis(4-methyl-6-tert-butylphenol) | [no description available] | medium | 1 | 0 | diarylmethane | |
| indolebutyric acid | [no description available] | medium | 1 | 0 | indol-3-yl carboxylic acid | auxin; plant hormone; plant metabolite |
| shikimic acid | [no description available] | medium | 1 | 0 | alpha,beta-unsaturated monocarboxylic acid; cyclohexenecarboxylic acid; hydroxy monocarboxylic acid | Escherichia coli metabolite; plant metabolite; Saccharomyces cerevisiae metabolite |
| monocrotaline | [no description available] | medium | 1 | 0 | pyrrolizidine alkaloid | |
| jervine | [no description available] | medium | 2 | 0 | piperidines | |
| glycyrrhetinic acid | [no description available] | medium | 1 | 0 | cyclic terpene ketone; hydroxy monocarboxylic acid; pentacyclic triterpenoid | immunomodulator; plant metabolite |
| boldine | [no description available] | medium | 1 | 0 | aporphine alkaloid | |
| indirubin | [no description available] | medium | 2 | 0 | ||
| plumbagin | [no description available] | medium | 1 | 0 | hydroxy-1,4-naphthoquinone; phenols | anticoagulant; antineoplastic agent; immunological adjuvant; metabolite |
| cepharanthine | [no description available] | medium | 1 | 0 | bisbenzylisoquinoline alkaloid; isoquinolines | |
| aloe emodin | [no description available] | medium | 1 | 0 | aromatic primary alcohol; dihydroxyanthraquinone | antineoplastic agent; plant metabolite |
| osthol | [no description available] | medium | 2 | 0 | botanical anti-fungal agent; coumarins | metabolite |
| cytisine | [no description available] | medium | 1 | 0 | alkaloid; bridged compound; lactam; organic heterotricyclic compound; secondary amino compound | nicotinic acetylcholine receptor agonist; phytotoxin; plant metabolite |
| bicuculline | [no description available] | medium | 1 | 0 | benzylisoquinoline alkaloid; isoquinoline alkaloid; isoquinolines | agrochemical; central nervous system stimulant; GABA-gated chloride channel antagonist; GABAA receptor antagonist; neurotoxin |
| kainic acid | [no description available] | medium | 1 | 0 | dicarboxylic acid; L-proline derivative; non-proteinogenic L-alpha-amino acid; pyrrolidinecarboxylic acid | antinematodal drug; excitatory amino acid agonist |
| thymoquinone | [no description available] | medium | 1 | 0 | 1,4-benzoquinones | adjuvant; anti-inflammatory agent; antidepressant; antineoplastic agent; antioxidant; cardioprotective agent; plant metabolite |
| oleanolic acid | [no description available] | medium | 2 | 0 | hydroxy monocarboxylic acid; pentacyclic triterpenoid | plant metabolite |
| podophyllotoxin | [no description available] | medium | 1 | 0 | furonaphthodioxole; lignan; organic heterotetracyclic compound | antimitotic; antineoplastic agent; keratolytic drug; microtubule-destabilising agent; plant metabolite; tubulin modulator |
| hesperidin | [no description available] | medium | 2 | 0 | 3'-hydroxyflavanones; 4'-methoxyflavanones; dihydroxyflavanone; disaccharide derivative; flavanone glycoside; monomethoxyflavanone; rutinoside | mutagen |
| azomycin | [no description available] | medium | 1 | 0 | C-nitro compound; imidazoles | antitubercular agent |
| Berberine chloride (TN) | [no description available] | medium | 1 | 0 | organic molecular entity | |
| vincamine | [no description available] | medium | 1 | 0 | alkaloid ester; hemiaminal; methyl ester; organic heteropentacyclic compound; vinca alkaloid | antihypertensive agent; metabolite; vasodilator agent |
| muscarine | [no description available] | medium | 1 | 0 | ||
| ecdysone | [no description available] | medium | 1 | 0 | 14alpha-hydroxy steroid; 22-hydroxy steroid; 25-hydroxy steroid; 2beta-hydroxy steroid; 3beta-sterol; 6-oxo steroid; ecdysteroid | prohormone |
| n-deacetyl-n-formylcolchicine | [no description available] | medium | 1 | 0 | cyclic ketone | |
| camptothecin | [no description available] | medium | 1 | 0 | delta-lactone; pyranoindolizinoquinoline; quinoline alkaloid; tertiary alcohol | antineoplastic agent; EC 5.99.1.2 (DNA topoisomerase) inhibitor; genotoxin; plant metabolite |
| tetradecanoylphorbol acetate | [no description available] | medium | 1 | 0 | acetate ester; diester; phorbol ester; tertiary alpha-hydroxy ketone; tetradecanoate ester | antineoplastic agent; apoptosis inducer; carcinogenic agent; mitogen; plant metabolite; protein kinase C agonist; reactive oxygen species generator |
| 2-bromoergocryptine mesylate | [no description available] | medium | 1 | 0 | methanesulfonate salt | antiparkinson drug |
| zingerone | [no description available] | medium | 1 | 0 | methyl ketone; monomethoxybenzene; phenols | anti-inflammatory agent; antiemetic; antioxidant; flavouring agent; fragrance; plant metabolite; radiation protective agent |
| paclitaxel | [no description available] | medium | 1 | 0 | taxane diterpenoid; tetracyclic diterpenoid | antineoplastic agent; human metabolite; metabolite; microtubule-stabilising agent |
| etoposide | [no description available] | medium | 1 | 0 | beta-D-glucoside; furonaphthodioxole; organic heterotetracyclic compound | antineoplastic agent; DNA synthesis inhibitor |
| phorbol 12,13-dibutyrate | [no description available] | medium | 1 | 0 | butyrate ester; phorbol ester; tertiary alpha-hydroxy ketone | |
| cephradine | [no description available] | medium | 1 | 0 | beta-lactam antibiotic allergen; cephalosporin | antibacterial drug |
| quisqualic acid | [no description available] | medium | 1 | 0 | non-proteinogenic alpha-amino acid | |
| colforsin | [no description available] | medium | 1 | 0 | acetate ester; cyclic ketone; labdane diterpenoid; organic heterotricyclic compound; tertiary alpha-hydroxy ketone; triol | adenylate cyclase agonist; anti-HIV agent; antihypertensive agent; plant metabolite; platelet aggregation inhibitor; protein kinase A agonist |
| swainsonine | [no description available] | medium | 1 | 0 | indolizidine alkaloid | antineoplastic agent; EC 3.2.1.114 (mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase) inhibitor; immunological adjuvant; plant metabolite |
| castanospermine | [no description available] | medium | 1 | 0 | indolizidine alkaloid | anti-HIV-1 agent; anti-inflammatory agent; EC 3.2.1.* (glycosidase) inhibitor; metabolite |
| daunorubicin hydrochloride | [no description available] | medium | 1 | 0 | anthracycline | |
| mevastatin | [no description available] | medium | 1 | 0 | 2-pyranones; carboxylic ester; hexahydronaphthalenes; polyketide; statin (naturally occurring) | antifungal agent; apoptosis inducer; EC 3.4.24.83 (anthrax lethal factor endopeptidase) inhibitor; fungal metabolite; Penicillium metabolite |
| ursolic acid | [no description available] | medium | 1 | 0 | hydroxy monocarboxylic acid; pentacyclic triterpenoid | geroprotector; plant metabolite |
| norharman | [no description available] | medium | 1 | 0 | beta-carbolines; mancude organic heterotricyclic parent | fungal metabolite; marine metabolite |
| betulinic acid | [no description available] | medium | 1 | 0 | hydroxy monocarboxylic acid; pentacyclic triterpenoid | anti-HIV agent; anti-inflammatory agent; antimalarial; antineoplastic agent; EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor; plant metabolite |
| epigallocatechin gallate | [no description available] | medium | 1 | 0 | flavans; gallate ester; polyphenol | antineoplastic agent; antioxidant; apoptosis inducer; geroprotector; Hsp90 inhibitor; neuroprotective agent; plant metabolite |
| baccatin iii | [no description available] | medium | 2 | 0 | acetate ester; benzoate ester; tetracyclic diterpenoid | plant metabolite |
| taleranol | [no description available] | medium | 1 | 0 | macrolide | |
| narasin | [no description available] | medium | 1 | 0 | diterpene glycoside | |
| quassin | [no description available] | medium | 1 | 0 | triterpenoid | |
| tomatidine | [no description available] | medium | 1 | 0 | 3beta-hydroxy steroid; azaspiro compound; oxaspiro compound | |
| aloxistatin | [no description available] | medium | 1 | 0 | epoxide; ethyl ester; L-leucine derivative; monocarboxylic acid amide | anticoronaviral agent; cathepsin B inhibitor |
| rutecarpine | [no description available] | medium | 1 | 0 | beta-carbolines | |
| bergenin | [no description available] | medium | 1 | 0 | trihydroxybenzoic acid | metabolite |
| pinocembrin | [no description available] | medium | 1 | 0 | (2S)-flavan-4-one; dihydroxyflavanone | antineoplastic agent; antioxidant; metabolite; neuroprotective agent; vasodilator agent |
| isoscopoletin | [no description available] | medium | 1 | 0 | aromatic ether; hydroxycoumarin | plant metabolite |
| vinburnine | [no description available] | medium | 1 | 0 | alkaloid | |
| epicatechin | [no description available] | medium | 2 | 0 | catechin; polyphenol | antioxidant |
| hesperetin | [no description available] | medium | 1 | 0 | 3'-hydroxyflavanones; 4'-methoxyflavanones; monomethoxyflavanone; trihydroxyflavanone | antineoplastic agent; antioxidant; plant metabolite |
| magnolol | [no description available] | medium | 1 | 0 | biphenyls | |
| honokiol | [no description available] | medium | 2 | 0 | biphenyls | |
| chelerythrine chloride | [no description available] | medium | 1 | 0 | ||
| betulin | [no description available] | medium | 1 | 0 | diol; pentacyclic triterpenoid | analgesic; anti-inflammatory agent; antineoplastic agent; antiviral agent; metabolite |
| tetrahydroalstonine | [no description available] | medium | 1 | 0 | methyl ester; organic heteropentacyclic compound; yohimban alkaloid | plant metabolite |
| hernandezine | [no description available] | medium | 1 | 0 | bisbenzylisoquinoline alkaloid; isoquinolines | |
| picropodophyllin | [no description available] | medium | 1 | 0 | furonaphthodioxole; lignan; organic heterotetracyclic compound | antineoplastic agent; insulin-like growth factor receptor 1 antagonist; plant metabolite; tyrosine kinase inhibitor |
| tetrandrine | [no description available] | medium | 1 | 0 | bisbenzylisoquinoline alkaloid; isoquinolines | |
| dehydrocostus lactone | [no description available] | medium | 1 | 0 | gamma-lactone; guaiane sesquiterpenoid; organic heterotricyclic compound; sesquiterpene lactone | antimycobacterial drug; antineoplastic agent; apoptosis inducer; cyclooxygenase 2 inhibitor; metabolite; trypanocidal drug |
| madecassic acid | [no description available] | medium | 1 | 0 | monocarboxylic acid; pentacyclic triterpenoid; tetrol | antioxidant; plant metabolite |
| panaxadiol | [no description available] | medium | 1 | 0 | triterpenoid saponin | |
| tryptanthrine | [no description available] | medium | 1 | 0 | alkaloid antibiotic; organic heterotetracyclic compound; organonitrogen heterocyclic compound | |
| homoeriodictyol | [no description available] | medium | 1 | 0 | 3'-methoxyflavanones; 4'-hydroxyflavanones; monomethoxyflavanone; trihydroxyflavanone | flavouring agent; metabolite |
| 4-hydroxyindole | [no description available] | medium | 1 | 0 | hydroxyindoles; phenols | |
| eriocitrin | [no description available] | medium | 2 | 0 | 3'-hydroxyflavanones; 4'-hydroxyflavanones; disaccharide derivative; flavanone glycoside; rutinoside; trihydroxyflavanone | antioxidant |
| 7,8-dihydromethysticin | [no description available] | medium | 1 | 0 | 2-pyranones; aromatic ether | |
| nicotine | [no description available] | medium | 1 | 0 | 3-(1-methylpyrrolidin-2-yl)pyridine | anxiolytic drug; biomarker; immunomodulator; mitogen; neurotoxin; nicotinic acetylcholine receptor agonist; peripheral nervous system drug; phytogenic insecticide; plant metabolite; psychotropic drug; teratogenic agent; xenobiotic |
| cinchonine | [no description available] | medium | 1 | 0 | (8xi)-cinchonan-9-ol; cinchona alkaloid | metabolite |
| aucubin | [no description available] | medium | 1 | 0 | organic molecular entity | metabolite |
| lupinine | [no description available] | medium | 2 | 0 | quinolizidine alkaloid | |
| matrine | [no description available] | medium | 1 | 0 | alkaloid | |
| friedelin | [no description available] | medium | 1 | 0 | cyclic terpene ketone; pentacyclic triterpenoid | anti-inflammatory drug; antipyretic; non-narcotic analgesic; plant metabolite |
| catalpol | [no description available] | medium | 1 | 0 | organic molecular entity | metabolite |
| quinine hydrochloride | [no description available] | medium | 1 | 0 | ||
| sarsasapogenin | [no description available] | medium | 1 | 0 | sapogenin | |
| corynanthine | [no description available] | medium | 1 | 0 | yohimban alkaloid | |
| prunin protein, prunus | [no description available] | medium | 1 | 0 | (2S)-flavan-4-one; 4'-hydroxyflavanones; dihydroxyflavanone; flavanone 7-O-beta-D-glucoside; monosaccharide derivative | antibacterial agent; antilipemic drug; hypoglycemic agent; metabolite |
| podocarpic acid | [no description available] | medium | 2 | 0 | abietane diterpenoid | |
| harmol hydrochloride | [no description available] | medium | 1 | 0 | ||
| 5-Methoxyflavone | [no description available] | medium | 1 | 0 | ether; flavonoids | |
| 10-hydroxycamptothecin | [no description available] | medium | 1 | 0 | pyranoindolizinoquinoline | |
| corydaline | [no description available] | medium | 1 | 0 | isoquinoline alkaloid; isoquinolines | |
| demissidine | [no description available] | medium | 1 | 0 | alkaloid; organic heteropolycyclic compound; steroid | |
| cinchonidine | [no description available] | medium | 1 | 0 | (8xi)-cinchonan-9-ol; cinchona alkaloid | metabolite |
| propidium iodide | [no description available] | medium | 1 | 0 | organic iodide salt | |
| tryptoline | [no description available] | medium | 2 | 0 | beta-carbolines | |
| deguelin | [no description available] | medium | 2 | 0 | aromatic ether; diether; organic heteropentacyclic compound; rotenones | angiogenesis inhibitor; anti-inflammatory agent; antineoplastic agent; antiviral agent; apoptosis inducer; EC 2.7.11.1 (non-specific serine/threonine protein kinase) inhibitor; mitochondrial NADH:ubiquinone reductase inhibitor; plant metabolite |
| catechin | [no description available] | medium | 1 | 0 | hydrate | geroprotector |
| daidzin | [no description available] | medium | 1 | 0 | 7-hydroxyisoflavones 7-O-beta-D-glucoside; hydroxyisoflavone; monosaccharide derivative | plant metabolite |
| cafestol | [no description available] | medium | 1 | 0 | diterpenoid; furans; organic heteropentacyclic compound; primary alcohol; tertiary alcohol | angiogenesis inhibitor; anti-inflammatory agent; antineoplastic agent; antioxidant; apoptosis inducer; hypoglycemic agent; plant metabolite |
| parthenolide | [no description available] | medium | 1 | 0 | germacranolide | |
| homoorientin | [no description available] | medium | 1 | 0 | flavone C-glycoside; tetrahydroxyflavone | antineoplastic agent; radical scavenger |
| asiatic acid | [no description available] | medium | 1 | 0 | monocarboxylic acid; pentacyclic triterpenoid; triol | angiogenesis modulating agent; metabolite |
| angustmycin a | [no description available] | medium | 1 | 0 | 6-aminopurines | |
| razadyne | [no description available] | medium | 1 | 0 | ||
| phytosphingosine | [no description available] | medium | 1 | 0 | amino alcohol; sphingoid; triol | mouse metabolite; Saccharomyces cerevisiae metabolite |
| tetradecanoylphorbol acetate | [no description available] | medium | 1 | 0 | ||
| celastrol | [no description available] | medium | 1 | 0 | monocarboxylic acid; pentacyclic triterpenoid | anti-inflammatory drug; antineoplastic agent; antioxidant; EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor; Hsp90 inhibitor; metabolite |
| 4'-demethylepipodophyllotoxin | [no description available] | medium | 1 | 0 | furonaphthodioxole; organic heterotetracyclic compound; phenols | antineoplastic agent |
| n-(n-(3-carboxyoxirane-2-carbonyl)leucyl)isoamylamine | [no description available] | medium | 1 | 0 | leucine derivative | |
| e 64 | [no description available] | medium | 1 | 0 | dicarboxylic acid monoamide; epoxy monocarboxylic acid; guanidines; L-leucine derivative; zwitterion | antimalarial; antiparasitic agent; protease inhibitor |
| sinensetin | [no description available] | medium | 1 | 0 | pentamethoxyflavone | plant metabolite |
| harmalol hydrochloride | [no description available] | medium | 1 | 0 | ||
| hyoscyamine | [no description available] | medium | 1 | 0 | tropane alkaloid | |
| schizandrin a | [no description available] | medium | 1 | 0 | ||
| schizandrin b | [no description available] | medium | 1 | 0 | aromatic ether; cyclic acetal; organic heterotetracyclic compound; oxacycle; tannin | anti-asthmatic agent; anti-inflammatory agent; antilipemic drug; antioxidant; apoptosis inhibitor; hepatoprotective agent; nephroprotective agent; neuroprotective agent; plant metabolite |
| cryptotanshinone | [no description available] | medium | 1 | 0 | abietane diterpenoid | anticoronaviral agent |
| isosakuranetin | [no description available] | medium | 1 | 0 | (2S)-flavan-4-one; 4'-methoxyflavanones; dihydroxyflavanone; monomethoxyflavanone | plant metabolite |
| isovitexin | [no description available] | medium | 1 | 0 | C-glycosyl compound; trihydroxyflavone | EC 3.2.1.20 (alpha-glucosidase) inhibitor; metabolite |
| sclareol | [no description available] | medium | 1 | 0 | labdane diterpenoid | antifungal agent; antimicrobial agent; apoptosis inducer; fragrance; plant metabolite |
| tanshinone ii a | [no description available] | medium | 1 | 0 | abietane diterpenoid | |
| leucodin | [no description available] | medium | 2 | 0 | sesquiterpene lactone | |
| limonin | [no description available] | medium | 1 | 0 | epoxide; furans; hexacyclic triterpenoid; lactone; limonoid; organic heterohexacyclic compound | inhibitor; metabolite; volatile oil component |
| maduramicin | [no description available] | medium | 1 | 0 | ||
| chelidonine | [no description available] | medium | 1 | 0 | alkaloid antibiotic; alkaloid fundamental parent; benzophenanthridine alkaloid | |
| troleandomycin | [no description available] | medium | 1 | 0 | acetate ester; epoxide; macrolide antibiotic; monosaccharide derivative; polyketide; semisynthetic derivative | EC 1.14.13.97 (taurochenodeoxycholate 6alpha-hydroxylase) inhibitor; xenobiotic |
| santonin | [no description available] | medium | 1 | 0 | botanical anti-fungal agent; santonin | plant metabolite |
| sitosterol, (3beta)-isomer | [no description available] | medium | 1 | 0 | 3beta-hydroxy-Delta(5)-steroid; 3beta-sterol; C29-steroid; phytosterols; stigmastane sterol | anticholesteremic drug; antioxidant; mouse metabolite; plant metabolite; sterol methyltransferase inhibitor |
| vincristine sulfate | [no description available] | medium | 1 | 0 | organic sulfate salt | antineoplastic agent; geroprotector |
| anisomycin | [no description available] | medium | 1 | 0 | monohydroxypyrrolidine; organonitrogen heterocyclic antibiotic | anticoronaviral agent; antimicrobial agent; antineoplastic agent; antiparasitic agent; bacterial metabolite; DNA synthesis inhibitor; protein synthesis inhibitor |
| acetylstrophanthidin | [no description available] | medium | 1 | 0 | acetate ester | anti-arrhythmia drug |
| Harringtonine | [no description available] | medium | 1 | 0 | alkaloid | |
| acivicin | [no description available] | medium | 1 | 0 | isoxazoles; non-proteinogenic L-alpha-amino acid; organochlorine compound | antileishmanial agent; antimetabolite; antimicrobial agent; antineoplastic agent; EC 2.3.2.2 (gamma-glutamyltransferase) inhibitor; glutamine antagonist; metabolite |
| ketopinic acid | [no description available] | medium | 1 | 0 | ||
| wortmannin | [no description available] | medium | 1 | 0 | acetate ester; cyclic ketone; delta-lactone; organic heteropentacyclic compound | anticoronaviral agent; antineoplastic agent; autophagy inhibitor; EC 2.7.1.137 (phosphatidylinositol 3-kinase) inhibitor; geroprotector; Penicillium metabolite; radiosensitizing agent |
| gitoxigenin | [no description available] | medium | 1 | 0 | 14beta-hydroxy steroid; 16beta-hydroxy steroid; 3beta-hydroxy steroid | |
| 4-oxy-6-(4-oxybezoyloxy)dauc-8,9-en | [no description available] | medium | 1 | 0 | ||
| naringenin | [no description available] | medium | 1 | 0 | (2S)-flavan-4-one; naringenin | expectorant; plant metabolite |
| ouabain | [no description available] | medium | 1 | 0 | 11alpha-hydroxy steroid; 14beta-hydroxy steroid; 5beta-hydroxy steroid; alpha-L-rhamnoside; cardenolide glycoside; steroid hormone | anti-arrhythmia drug; cardiotonic drug; EC 2.3.3.1 [citrate (Si)-synthase] inhibitor; EC 3.1.3.41 (4-nitrophenylphosphatase) inhibitor; EC 3.6.3.10 (H(+)/K(+)-exchanging ATPase) inhibitor; EC 3.6.3.9 (Na(+)/K(+)-transporting ATPase) inhibitor; ion transport inhibitor; plant metabolite |
| puromycin | [no description available] | medium | 1 | 0 | puromycins | antiinfective agent; antimicrobial agent; antineoplastic agent; EC 3.4.11.14 (cytosol alanyl aminopeptidase) inhibitor; EC 3.4.14.2 (dipeptidyl-peptidase II) inhibitor; nucleoside antibiotic; protein synthesis inhibitor |
| taxifolin | [no description available] | medium | 2 | 0 | taxifolin | metabolite |
| mimosine | [no description available] | medium | 1 | 0 | 4-pyridones; amino acid zwitterion; non-proteinogenic L-alpha-amino acid | EC 1.14.18.1 (tyrosinase) inhibitor; plant metabolite |
| eriodictyol | [no description available] | medium | 1 | 0 | 3'-hydroxyflavanones; tetrahydroxyflavanone | |
| arbutin | [no description available] | medium | 1 | 0 | beta-D-glucoside; monosaccharide derivative | Escherichia coli metabolite; plant metabolite |
| quinidine | [no description available] | medium | 1 | 0 | cinchona alkaloid | alpha-adrenergic antagonist; anti-arrhythmia drug; antimalarial; drug allergen; EC 1.14.13.181 (13-deoxydaunorubicin hydroxylase) inhibitor; EC 3.6.3.44 (xenobiotic-transporting ATPase) inhibitor; muscarinic antagonist; P450 inhibitor; potassium channel blocker; sodium channel blocker |
| conessine | [no description available] | medium | 1 | 0 | steroid alkaloid; tertiary amino compound | antibacterial agent; antimalarial; H3-receptor antagonist; plant metabolite |
| griseofulvin | [no description available] | medium | 1 | 0 | 1-benzofurans; antibiotic antifungal drug; benzofuran antifungal drug; organochlorine compound; oxaspiro compound | antibacterial agent; Penicillium metabolite |
| digitoxin | [no description available] | medium | 2 | 0 | cardenolide glycoside | EC 3.6.3.9 (Na(+)/K(+)-transporting ATPase) inhibitor |
| hyperforin | [no description available] | medium | 1 | 0 | ||
| deltaline | [no description available] | medium | 1 | 0 | acetate ester; cyclic acetal; diterpene alkaloid; organic polycyclic compound; tertiary alcohol; tertiary amino compound | |
| ingenol | [no description available] | medium | 1 | 0 | cyclic terpene ketone; tetracyclic diterpenoid | |
| picrotin | [no description available] | medium | 1 | 0 | diol; epoxide; gamma-lactone; organic heteropentacyclic compound; picrotoxane sesquiterpenoid; tertiary alcohol | plant metabolite |
| picrotoxinin | [no description available] | medium | 1 | 0 | epoxide; gamma-lactone; organic heteropentacyclic compound; picrotoxane sesquiterpenoid; tertiary alcohol | GABA antagonist; plant metabolite; serotonergic antagonist |
| naringin | [no description available] | medium | 1 | 0 | (2S)-flavan-4-one; 4'-hydroxyflavanones; dihydroxyflavanone; disaccharide derivative; neohesperidoside | anti-inflammatory agent; antineoplastic agent; metabolite |
| isonaringin | [no description available] | medium | 1 | 0 | (2S)-flavan-4-one; 4'-hydroxyflavanones; dihydroxyflavanone; disaccharide derivative; rutinoside | anti-inflammatory agent; antioxidant; metabolite |
| ochratoxin a | [no description available] | medium | 1 | 0 | isochromanes; monocarboxylic acid amide; N-acyl-L-phenylalanine; organochlorine compound; phenylalanine derivative | Aspergillus metabolite; calcium channel blocker; carcinogenic agent; mycotoxin; nephrotoxin; Penicillium metabolite; teratogenic agent |
| gingerol | [no description available] | medium | 1 | 0 | beta-hydroxy ketone; guaiacols | antineoplastic agent; plant metabolite |
| securinine | [no description available] | medium | 1 | 0 | indolizines | |
| Dubinidine | [no description available] | medium | 1 | 0 | organic heterotricyclic compound; organonitrogen heterocyclic compound; oxacycle | |
| cyclopamine | [no description available] | medium | 1 | 0 | piperidines | glioma-associated oncogene inhibitor |
| doxorubicin hydrochloride | [no description available] | medium | 1 | 0 | anthracycline | |
| vinpocetine | [no description available] | medium | 1 | 0 | alkaloid | geroprotector |
| dihydroergocristine monomesylate | [no description available] | medium | 2 | 0 | methanesulfonate salt | alpha-adrenergic antagonist; geroprotector; vasodilator agent |
| tretinoin | [no description available] | medium | 1 | 0 | retinoic acid; vitamin A | anti-inflammatory agent; antineoplastic agent; antioxidant; AP-1 antagonist; human metabolite; keratolytic drug; retinoic acid receptor agonist; retinoid X receptor agonist; signalling molecule |
| resveratrol | [no description available] | medium | 1 | 0 | resveratrol | antioxidant; phytoalexin; plant metabolite; quorum sensing inhibitor; radical scavenger |
| ferulic acid | [no description available] | medium | 1 | 0 | ferulic acids | anti-inflammatory agent; antioxidant; apoptosis inhibitor; cardioprotective agent; MALDI matrix material; plant metabolite |
| thapsigargin | [no description available] | medium | 1 | 0 | butyrate ester; organic heterotricyclic compound; sesquiterpene lactone | calcium channel blocker; EC 3.6.3.8 (Ca(2+)-transporting ATPase) inhibitor |
| mycophenolic acid | [no description available] | medium | 2 | 0 | 2-benzofurans; gamma-lactone; monocarboxylic acid; phenols | anticoronaviral agent; antimicrobial agent; antineoplastic agent; EC 1.1.1.205 (IMP dehydrogenase) inhibitor; environmental contaminant; immunosuppressive agent; mycotoxin; Penicillium metabolite; xenobiotic |
| alitretinoin | [no description available] | medium | 1 | 0 | retinoic acid | antineoplastic agent; keratolytic drug; metabolite; retinoid X receptor agonist |
| L-cycloserine | [no description available] | medium | 1 | 0 | 4-amino-1,2-oxazolidin-3-one | anti-HIV agent; anticonvulsant; EC 2.3.1.50 (serine C-palmitoyltransferase) inhibitor |
| 12-deoxyphorbol 13-acetate | [no description available] | medium | 1 | 0 | phorbol ester | metabolite |
| dactinomycin | [no description available] | medium | 1 | 0 | actinomycin | mutagen |
| aphidicolin | [no description available] | medium | 2 | 0 | tetracyclic diterpenoid | antimicrobial agent; antimitotic; antineoplastic agent; antiviral drug; apoptosis inducer; Aspergillus metabolite; DNA synthesis inhibitor; EC 2.7.7.7 (DNA-directed DNA polymerase) inhibitor; fungal metabolite |
| (+)-usnic acid | [no description available] | medium | 1 | 0 | usnic acid | |
| beta, beta-dimethylacrylshikonin, (+)-isomer | [no description available] | medium | 1 | 0 | hydroxy-1,4-naphthoquinone | |
| shikonin | [no description available] | medium | 1 | 0 | hydroxy-1,4-naphthoquinone | |
| rhapontin | [no description available] | medium | 1 | 0 | rhaponticin | angiogenesis inhibitor; anti-allergic agent; anti-inflammatory agent; antilipemic drug; antineoplastic agent; apoptosis inducer; EC 2.3.1.85 (fatty acid synthase) inhibitor; hypoglycemic agent; neuroprotective agent; plant metabolite |
| piperine | [no description available] | medium | 1 | 0 | benzodioxoles; N-acylpiperidine; piperidine alkaloid; tertiary carboxamide | food component; human blood serum metabolite; NF-kappaB inhibitor; plant metabolite |
| rauwolscine | [no description available] | medium | 1 | 0 | methyl 17-hydroxy-20xi-yohimban-16-carboxylate | |
| amygdalin | [no description available] | medium | 1 | 0 | amygdalin | antineoplastic agent; apoptosis inducer; plant metabolite |
| hydrastine, (r-(r*,s*))-isomer | [no description available] | medium | 1 | 0 | isoquinolines | |
| vasicine | [no description available] | medium | 2 | 0 | ||
| 3,3',4,5'-tetrahydroxystilbene | [no description available] | medium | 1 | 0 | catechols; polyphenol; resorcinols; stilbenol | antineoplastic agent; apoptosis inducer; geroprotector; hypoglycemic agent; plant metabolite; protein kinase inhibitor; tyrosine kinase inhibitor |
| caffeic acid | [no description available] | medium | 1 | 0 | caffeic acid | geroprotector; mouse metabolite |
| cotinine | [no description available] | medium | 1 | 0 | N-alkylpyrrolidine; pyridines; pyrrolidin-2-ones; pyrrolidine alkaloid | antidepressant; biomarker; human xenobiotic metabolite; plant metabolite |
| heliotrine | [no description available] | medium | 1 | 0 | pyrrolizines | |
| sclareolide | [no description available] | medium | 1 | 0 | naphthofuran | |
| hypocrellin b | [no description available] | medium | 1 | 0 | ||
| capsaicin | [no description available] | medium | 1 | 0 | capsaicinoid | non-narcotic analgesic; TRPV1 agonist; voltage-gated sodium channel blocker |
| aurapten | [no description available] | medium | 1 | 0 | coumarins; monoterpenoid | antihypertensive agent; antineoplastic agent; antioxidant; apoptosis inducer; dopaminergic agent; EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor; gamma-secretase modulator; gastrointestinal drug; hepatoprotective agent; matrix metalloproteinase inhibitor; neuroprotective agent; plant metabolite; PPARalpha agonist; vulnerary |
| chlorogenic acid | [no description available] | medium | 1 | 0 | cinnamate ester; tannin | food component; plant metabolite |
| fumonisin b2 | [no description available] | medium | 1 | 0 | diester; diol; fumonisin; primary amino compound | Aspergillus metabolite; carcinogenic agent |
| lincomycin | [no description available] | medium | 1 | 0 | carbohydrate-containing antibiotic; L-proline derivative; monocarboxylic acid amide; pyrrolidinecarboxamide; S-glycosyl compound | antimicrobial agent; bacterial metabolite |
| valinomycin | [no description available] | medium | 1 | 0 | cyclodepsipeptide; macrocycle | antimicrobial agent; antiviral agent; bacterial metabolite; potassium ionophore |
| orlistat | [no description available] | medium | 1 | 0 | beta-lactone; carboxylic ester; formamides; L-leucine derivative | anti-obesity agent; bacterial metabolite; EC 2.3.1.85 (fatty acid synthase) inhibitor; EC 3.1.1.3 (triacylglycerol lipase) inhibitor |
| 12-deoxyphorbolphenylacetate-20-acetate | [no description available] | medium | 1 | 0 | ||
| brassinin | [no description available] | medium | 1 | 0 | dithiocarbamic ester; indole phytoalexin | |
| chaetomellic acid a | [no description available] | medium | 1 | 0 | ||
| hirsutine | [no description available] | medium | 1 | 0 | ||
| 3-deoxyvasicine, hydrochloride | [no description available] | medium | 1 | 0 | ||
| emetine dihydrochloride | [no description available] | medium | 1 | 0 | hydrochloride | anticoronaviral agent; antimalarial; antineoplastic agent; antiprotozoal drug; antiviral agent; autophagy inhibitor; emetic; protein synthesis inhibitor |
| salinomycin | [no description available] | medium | 1 | 0 | polyketide; spiroketal | animal growth promotant; potassium ionophore |
| silybin | [no description available] | medium | 1 | 0 | ||
| 5,6-dehydrokawain | [no description available] | medium | 2 | 0 | 2-pyranones; aromatic ether | |
| 9,10-dihydrolysergol | [no description available] | medium | 1 | 0 | ||
| geranylgeranic acid | [no description available] | medium | 1 | 0 | alpha,beta-unsaturated monocarboxylic acid; diterpenoid; methyl-branched fatty acid; trienoic fatty acid | |
| quercetin | [no description available] | medium | 1 | 0 | 7-hydroxyflavonol; pentahydroxyflavone | antibacterial agent; antineoplastic agent; antioxidant; Aurora kinase inhibitor; chelator; EC 1.10.99.2 [ribosyldihydronicotinamide dehydrogenase (quinone)] inhibitor; geroprotector; phytoestrogen; plant metabolite; protein kinase inhibitor; radical scavenger |
| dinoprostone | [no description available] | medium | 1 | 0 | prostaglandins E | human metabolite; mouse metabolite; oxytocic |
| dinoprost | [no description available] | medium | 1 | 0 | monocarboxylic acid; prostaglandins Falpha | human metabolite; mouse metabolite |
| biochanin a | [no description available] | medium | 1 | 0 | 4'-methoxyisoflavones; 7-hydroxyisoflavones | antineoplastic agent; EC 3.5.1.99 (fatty acid amide hydrolase) inhibitor; phytoestrogen; plant metabolite; tyrosine kinase inhibitor |
| formononetin | [no description available] | medium | 1 | 0 | 4'-methoxyisoflavones; 7-hydroxyisoflavones | phytoestrogen; plant metabolite |
| prostaglandin b1 | [no description available] | medium | 2 | 0 | prostaglandins B | human metabolite |
| sterigmatocystin | [no description available] | medium | 1 | 0 | sterigmatocystins | metabolite |
| vitexin | [no description available] | medium | 1 | 0 | C-glycosyl compound; trihydroxyflavone | antineoplastic agent; EC 3.2.1.20 (alpha-glucosidase) inhibitor; plant metabolite; platelet aggregation inhibitor |
| acacetin | [no description available] | medium | 1 | 0 | dihydroxyflavone; monomethoxyflavone | anticonvulsant; plant metabolite |
| apigenin | [no description available] | medium | 1 | 0 | trihydroxyflavone | antineoplastic agent; metabolite |
| luteolin | [no description available] | medium | 1 | 0 | 3'-hydroxyflavonoid; tetrahydroxyflavone | angiogenesis inhibitor; anti-inflammatory agent; antineoplastic agent; apoptosis inducer; c-Jun N-terminal kinase inhibitor; EC 2.3.1.85 (fatty acid synthase) inhibitor; immunomodulator; nephroprotective agent; plant metabolite; radical scavenger; vascular endothelial growth factor receptor antagonist |
| quercitrin | [no description available] | medium | 1 | 0 | alpha-L-rhamnoside; monosaccharide derivative; quercetin O-glycoside; tetrahydroxyflavone | antileishmanial agent; antioxidant; EC 1.1.1.184 [carbonyl reductase (NADPH)] inhibitor; EC 1.1.1.21 (aldehyde reductase) inhibitor; EC 1.14.18.1 (tyrosinase) inhibitor; plant metabolite |
| scopoletin | [no description available] | medium | 1 | 0 | hydroxycoumarin | plant growth regulator; plant metabolite |
| hymecromone | [no description available] | medium | 1 | 0 | hydroxycoumarin | antineoplastic agent; hyaluronic acid synthesis inhibitor |
| alprostadil | [no description available] | medium | 1 | 0 | prostaglandins E | anticoagulant; human metabolite; platelet aggregation inhibitor; vasodilator agent |
| quercetin 3-o-glucopyranoside | [no description available] | medium | 2 | 0 | beta-D-glucoside; monosaccharide derivative; quercetin O-glucoside; tetrahydroxyflavone | antineoplastic agent; antioxidant; antipruritic drug; bone density conservation agent; geroprotector; histamine antagonist; osteogenesis regulator; plant metabolite |
| rutin | [no description available] | medium | 1 | 0 | disaccharide derivative; quercetin O-glucoside; rutinoside; tetrahydroxyflavone | antioxidant; metabolite |
| kaempferol | [no description available] | medium | 1 | 0 | 7-hydroxyflavonol; flavonols; tetrahydroxyflavone | antibacterial agent; geroprotector; human blood serum metabolite; human urinary metabolite; human xenobiotic metabolite; plant metabolite |
| senecionine | [no description available] | medium | 1 | 0 | lactone; pyrrolizidine alkaloid; tertiary alcohol | plant metabolite |
| genistein | [no description available] | medium | 1 | 0 | 7-hydroxyisoflavones | antineoplastic agent; EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor; geroprotector; human urinary metabolite; phytoestrogen; plant metabolite; tyrosine kinase inhibitor |
| amphotericin b | [no description available] | medium | 1 | 0 | antibiotic antifungal drug; macrolide antibiotic; polyene antibiotic | antiamoebic agent; antiprotozoal drug; bacterial metabolite |
| butein | [no description available] | medium | 1 | 0 | chalcones; polyphenol | antineoplastic agent; antioxidant; EC 1.1.1.21 (aldehyde reductase) inhibitor; geroprotector; hypoglycemic agent; plant metabolite; radiosensitizing agent; tyrosine kinase inhibitor |
| sulfuretin | [no description available] | medium | 1 | 0 | 1-benzofurans | |
| genistin | [no description available] | medium | 1 | 0 | 7-hydroxyisoflavones 7-O-beta-D-glucoside | |
| chartreusin | [no description available] | medium | 2 | 0 | benzochromenone; glycoside | |
| methysticin | [no description available] | medium | 1 | 0 | 2-pyranones; aromatic ether | |
| yangonin | [no description available] | medium | 1 | 0 | 2-pyranones; aromatic ether | |
| zearalenone | [no description available] | medium | 1 | 0 | macrolide; resorcinols | fungal metabolite; mycoestrogen |
| baicalein | [no description available] | medium | 1 | 0 | trihydroxyflavone | angiogenesis inhibitor; anti-inflammatory agent; antibacterial agent; anticoronaviral agent; antifungal agent; antineoplastic agent; antioxidant; apoptosis inducer; EC 1.13.11.31 (arachidonate 12-lipoxygenase) inhibitor; EC 1.13.11.33 (arachidonate 15-lipoxygenase) inhibitor; EC 3.4.21.26 (prolyl oligopeptidase) inhibitor; EC 3.4.22.69 (SARS coronavirus main proteinase) inhibitor; EC 4.1.1.17 (ornithine decarboxylase) inhibitor; ferroptosis inhibitor; geroprotector; hormone antagonist; plant metabolite; prostaglandin antagonist; radical scavenger |
| chrysin | [no description available] | medium | 2 | 0 | 7-hydroxyflavonol; dihydroxyflavone | anti-inflammatory agent; antineoplastic agent; antioxidant; EC 2.7.11.18 (myosin-light-chain kinase) inhibitor; hepatoprotective agent; plant metabolite |
| datiscetin | [no description available] | medium | 1 | 0 | 7-hydroxyflavonol; tetrahydroxyflavone | |
| diosmetin | [no description available] | medium | 1 | 0 | 3'-hydroxyflavonoid; monomethoxyflavone; trihydroxyflavone | angiogenesis inhibitor; anti-inflammatory agent; antineoplastic agent; antioxidant; apoptosis inducer; bone density conservation agent; cardioprotective agent; plant metabolite; tropomyosin-related kinase B receptor agonist; vasodilator agent |
| diosmin | [no description available] | medium | 1 | 0 | dihydroxyflavanone; disaccharide derivative; glycosyloxyflavone; monomethoxyflavone; rutinoside | anti-inflammatory agent; antioxidant |
| fisetin | [no description available] | medium | 1 | 0 | 3'-hydroxyflavonoid; 7-hydroxyflavonol; tetrahydroxyflavone | anti-inflammatory agent; antioxidant; EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor; geroprotector; metabolite; plant metabolite |
| galangin | [no description available] | medium | 1 | 0 | 7-hydroxyflavonol; trihydroxyflavone | antimicrobial agent; EC 3.1.1.3 (triacylglycerol lipase) inhibitor; plant metabolite |
| 3-methylquercetin | [no description available] | medium | 1 | 0 | 7-hydroxyflavonol; monomethoxyflavone; tetrahydroxyflavone | anticoagulant; EC 1.14.18.1 (tyrosinase) inhibitor; metabolite |
| morin | [no description available] | medium | 1 | 0 | 7-hydroxyflavonol; pentahydroxyflavone | angiogenesis modulating agent; anti-inflammatory agent; antibacterial agent; antihypertensive agent; antineoplastic agent; antioxidant; EC 5.99.1.2 (DNA topoisomerase) inhibitor; hepatoprotective agent; metabolite; neuroprotective agent |
| myricetin | [no description available] | medium | 1 | 0 | 7-hydroxyflavonol; hexahydroxyflavone | antineoplastic agent; antioxidant; cyclooxygenase 1 inhibitor; food component; geroprotector; hypoglycemic agent; plant metabolite |
| rhamnetin | [no description available] | medium | 1 | 0 | monomethoxyflavone; tetrahydroxyflavone | anti-inflammatory agent; antioxidant; metabolite |
| robinetin | [no description available] | medium | 1 | 0 | 7-hydroxyflavonol; pentahydroxyflavone | plant metabolite |
| tamarixetin | [no description available] | medium | 1 | 0 | 7-hydroxyflavonol; monomethoxyflavone; tetrahydroxyflavone | antioxidant; metabolite |
| wogonin | [no description available] | medium | 1 | 0 | dihydroxyflavone; monomethoxyflavone | angiogenesis inhibitor; antineoplastic agent; cyclooxygenase 2 inhibitor; plant metabolite |
| coumestrol | [no description available] | medium | 2 | 0 | coumestans; delta-lactone; polyphenol | anti-inflammatory agent; antioxidant; plant metabolite |
| daidzein | [no description available] | medium | 1 | 0 | 7-hydroxyisoflavones | antineoplastic agent; EC 2.7.7.7 (DNA-directed DNA polymerase) inhibitor; EC 3.2.1.20 (alpha-glucosidase) inhibitor; phytoestrogen; plant metabolite |
| caffeic acid phenethyl ester | [no description available] | medium | 2 | 0 | alkyl caffeate ester | anti-inflammatory agent; antibacterial agent; antineoplastic agent; antioxidant; antiviral agent; immunomodulator; metabolite; neuroprotective agent |
| rosmarinic acid | [no description available] | medium | 1 | 0 | rosmarinic acid | geroprotector; plant metabolite |
| wedelolactone | [no description available] | medium | 1 | 0 | aromatic ether; coumestans; delta-lactone; polyphenol | antineoplastic agent; apoptosis inducer; EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor; hepatoprotective agent; metabolite |
| rottlerin | [no description available] | medium | 1 | 0 | aromatic ketone; benzenetriol; chromenol; enone; methyl ketone | anti-allergic agent; antihypertensive agent; antineoplastic agent; apoptosis inducer; K-ATP channel agonist; metabolite |
| ellagic acid | [no description available] | medium | 1 | 0 | catechols; cyclic ketone; lactone; organic heterotetracyclic compound; polyphenol | antioxidant; EC 1.14.18.1 (tyrosinase) inhibitor; EC 2.3.1.5 (arylamine N-acetyltransferase) inhibitor; EC 2.4.1.1 (glycogen phosphorylase) inhibitor; EC 2.5.1.18 (glutathione transferase) inhibitor; EC 2.7.1.127 (inositol-trisphosphate 3-kinase) inhibitor; EC 2.7.1.151 (inositol-polyphosphate multikinase) inhibitor; EC 2.7.4.6 (nucleoside-diphosphate kinase) inhibitor; EC 2.7.7.7 (DNA-directed DNA polymerase) inhibitor; EC 5.99.1.2 (DNA topoisomerase) inhibitor; EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor; food additive; fungal metabolite; geroprotector; plant metabolite; skin lightening agent |
| 7-hydroxyflavone | [no description available] | medium | 2 | 0 | hydroxyflavonoid | |
| prostaglandin a1 | [no description available] | medium | 1 | 0 | prostaglandins A | |
| cerulenin | [no description available] | medium | 1 | 0 | epoxide; monocarboxylic acid amide | antifungal agent; antiinfective agent; antilipemic drug; antimetabolite; antimicrobial agent; fatty acid synthesis inhibitor |
| rhoifolin | [no description available] | medium | 1 | 0 | dihydroxyflavone; glycosyloxyflavone; neohesperidoside | metabolite |
| vitexin rhamnoside | [no description available] | medium | 1 | 0 | C-glycosyl compound; disaccharide derivative; trihydroxyflavone | plant metabolite |
| domoic acid | [no description available] | medium | 1 | 0 | L-proline derivative; non-proteinogenic L-alpha-amino acid; pyrrolidinecarboxylic acid; tricarboxylic acid | algal metabolite; hapten; marine metabolite; neuromuscular agent; neurotoxin |
| isotretinoin | [no description available] | medium | 1 | 0 | retinoic acid | antineoplastic agent; keratolytic drug; teratogenic agent |
| cyclosporine | [no description available] | medium | 1 | 0 | homodetic cyclic peptide | anti-asthmatic drug; anticoronaviral agent; antifungal agent; antirheumatic drug; carcinogenic agent; dermatologic drug; EC 3.1.3.16 (phosphoprotein phosphatase) inhibitor; geroprotector; immunosuppressive agent; metabolite |
| natamycin | [no description available] | medium | 2 | 0 | antibiotic antifungal drug; dicarboxylic acid monoester; epoxide; macrolide antibiotic; monosaccharide derivative; polyene antibiotic | antifungal agrochemical; antimicrobial food preservative; apoptosis inducer; bacterial metabolite; ophthalmology drug |
| sirolimus | [no description available] | medium | 1 | 0 | antibiotic antifungal drug; cyclic acetal; cyclic ketone; ether; macrolide lactam; organic heterotricyclic compound; secondary alcohol | antibacterial drug; anticoronaviral agent; antineoplastic agent; bacterial metabolite; geroprotector; immunosuppressive agent; mTOR inhibitor |
| brefeldin a | [no description available] | medium | 1 | 0 | macrolide antibiotic | Penicillium metabolite |
| cytochalasin b | [no description available] | medium | 1 | 0 | cytochalasin; lactam; lactone; organic heterotricyclic compound | actin polymerisation inhibitor; metabolite; mycotoxin; platelet aggregation inhibitor |
| vinorelbine | [no description available] | medium | 1 | 0 | acetate ester; methyl ester; organic heteropentacyclic compound; organic heterotetracyclic compound; ring assembly; vinca alkaloid | antineoplastic agent; photosensitizing agent |
| bisdemethoxycurcumin | [no description available] | medium | 1 | 0 | beta-diketone; diarylheptanoid; enone; polyphenol | EC 3.2.1.1 (alpha-amylase) inhibitor; metabolite |
| andrographolide | [no description available] | medium | 1 | 0 | carbobicyclic compound; gamma-lactone; labdane diterpenoid; primary alcohol; secondary alcohol | anti-HIV agent; anti-inflammatory drug; antineoplastic agent; metabolite |
| isorhamnetin 3-o-glucoside | [no description available] | medium | 1 | 0 | beta-D-glucoside; glycosyloxyflavone; monomethoxyflavone; monosaccharide derivative; trihydroxyflavone | metabolite |
| 6,7-dihydroxyflavone | [no description available] | medium | 1 | 0 | ||
| flavokawain a | [no description available] | medium | 1 | 0 | chalcones | |
| flavokawain b | [no description available] | medium | 1 | 0 | chalcones; dimethoxybenzene; phenols | anti-inflammatory agent; antileishmanial agent; antineoplastic agent; apoptosis inducer; metabolite |
| kavain | [no description available] | medium | 1 | 0 | racemate | glycine receptor antagonist |
| abscisic acid, (+,-)-isomer | [no description available] | medium | 1 | 0 | abscisic acids | abscisic acid receptor agonist |
| veratrine | [no description available] | medium | 2 | 0 | alkaloid | |
| vinblastine sulfate | [no description available] | medium | 1 | 0 | ||
| catharanthine | [no description available] | medium | 1 | 0 | alkaloid ester; bridged compound; methyl ester; monoterpenoid indole alkaloid; organic heteropentacyclic compound; tertiary amino compound | |
| cytochalasin e | [no description available] | medium | 1 | 0 | cytochalasan alkaloid | metabolite |
| cytochalasin d | [no description available] | medium | 1 | 0 | ||
| sinomenine | [no description available] | medium | 1 | 0 | morphinane alkaloid | |
| ecdysterone | [no description available] | medium | 1 | 0 | 14alpha-hydroxy steroid; 20-hydroxy steroid; 22-hydroxy steroid; 25-hydroxy steroid; 2beta-hydroxy steroid; 3beta-sterol; ecdysteroid; phytoecdysteroid | animal metabolite; plant metabolite |
| bleomycin | [no description available] | medium | 1 | 0 | bleomycin | antineoplastic agent; metabolite |
| bakuchiol | [no description available] | medium | 1 | 0 | ||
| zerumbone | [no description available] | medium | 1 | 0 | cyclic ketone; sesquiterpenoid | anti-inflammatory agent; glioma-associated oncogene inhibitor; plant metabolite |
| solanesol | [no description available] | medium | 1 | 0 | nonaprenol; primary alcohol | plant metabolite |
| (1S,15S,17R,18R,19S,20S)-6,18-dimethoxy-17-[oxo-(3,4,5-trimethoxyphenyl)methoxy]-1,3,11,12,14,15,16,17,18,19,20,21-dodecahydroyohimban-19-carboxylic acid methyl ester | [no description available] | medium | 1 | 0 | yohimban alkaloid | |
| n-caproylsphingosine | [no description available] | medium | 1 | 0 | N-acylsphingosine | |
| monorden | [no description available] | medium | 2 | 0 | cyclic ketone; enone; epoxide; macrolide antibiotic; monochlorobenzenes; phenols | antifungal agent; metabolite; tyrosine kinase inhibitor |
| ginkgolide b | [no description available] | medium | 1 | 0 | ||
| homatropine hydrobromide, (endo-(+-)-isomer) | [no description available] | medium | 1 | 0 | ||
| hydrocotarnine hydrobromide | [no description available] | medium | 1 | 0 | ||
| salsolinol hydrobromide | [no description available] | medium | 1 | 0 | ||
| lasalocid sodium | [no description available] | medium | 1 | 0 | benzoates; organic sodium salt | coccidiostat; ionophore |
| sclerotiorin | [no description available] | medium | 1 | 0 | azaphilone | |
| himbacine | [no description available] | medium | 1 | 0 | gamma-lactone; organic heterotricyclic compound; piperidine alkaloid | muscarinic antagonist |
| ebelactone b | [no description available] | medium | 1 | 0 | ||
| 3-o-methylbutein | [no description available] | medium | 1 | 0 | chalcones | |
| thermozymocidin | [no description available] | medium | 1 | 0 | alpha-amino fatty acid; hydroxy monocarboxylic acid; non-proteinogenic alpha-amino acid; sphingoid | antifungal agent; antimicrobial agent; antineoplastic agent; apoptosis inducer; EC 2.3.1.50 (serine C-palmitoyltransferase) inhibitor; fungal metabolite; immunosuppressive agent |
| marein | [no description available] | medium | 1 | 0 | flavonoids; glycoside | |
| hydroxyachillin | [no description available] | medium | 1 | 0 | gamma-lactone | |
| butylscopolammonium bromide | [no description available] | medium | 1 | 0 | ||
| fumagillin | [no description available] | medium | 1 | 0 | antibiotic antifungal drug; carboxylic ester; dicarboxylic acid monoester; meroterpenoid; organooxygen heterocyclic antibiotic; spiro-epoxide | angiogenesis inhibitor; antibacterial drug; antimicrobial agent; antiprotozoal drug; fungal metabolite; methionine aminopeptidase 2 inhibitor |
| artesunate | [no description available] | medium | 1 | 0 | artemisinin derivative; cyclic acetal; dicarboxylic acid monoester; hemisuccinate; semisynthetic derivative; sesquiterpenoid | antimalarial; antineoplastic agent; ferroptosis inducer |
| anisodamine | [no description available] | medium | 1 | 0 | ||
| bufalin | [no description available] | medium | 1 | 0 | 14beta-hydroxy steroid; 3beta-hydroxy steroid | animal metabolite; anti-inflammatory agent; antineoplastic agent; cardiotonic drug |
| alpha-solanine | [no description available] | medium | 1 | 0 | glycoalkaloid; organic heterohexacyclic compound; steroid saponin; trisaccharide derivative | antineoplastic agent; apoptosis inducer; phytotoxin; plant metabolite |
| apigenin-7-o-rutinoside | [no description available] | medium | 1 | 0 | ||
| gambogic acid | [no description available] | medium | 1 | 0 | pyranoxanthones | metabolite |
| bn 52020 | [no description available] | medium | 1 | 0 | ||
| carmine | [no description available] | medium | 1 | 0 | C-glycosyl compound; monocarboxylic acid; tetrahydroxyanthraquinone | animal metabolite; histological dye |
| bavachinin | [no description available] | medium | 1 | 0 | flavanones | |
| grayanotoxin iii | [no description available] | medium | 1 | 0 | ||
| Dihydrotanshinone I | [no description available] | medium | 1 | 0 | abietane diterpenoid | anticoronaviral agent |
| calcimycin | [no description available] | medium | 1 | 0 | benzoxazole | |
| cinobufagin | [no description available] | medium | 2 | 0 | steroid lactone | |
| atropine sulfate | [no description available] | medium | 1 | 0 | ||
| cannogenin thevetoside | [no description available] | medium | 1 | 0 | cardenolide glycoside | |
| eriodictyol 7-O-beta-D-glucopyranoside | [no description available] | medium | 1 | 0 | beta-D-glucoside; flavanone glycoside; monosaccharide derivative; trihydroxyflavanone | plant metabolite; radical scavenger |
| hypocrellin a | [no description available] | medium | 1 | 0 | ||
| dihydrorobinetin | [no description available] | medium | 1 | 0 | ||
| monensin | [no description available] | medium | 1 | 0 | ||
| minocycline | [no description available] | medium | 1 | 0 | ||
| dicumarol | [no description available] | medium | 1 | 0 | hydroxycoumarin | anticoagulant; EC 1.6.5.2 [NAD(P)H dehydrogenase (quinone)] inhibitor; Hsp90 inhibitor; vitamin K antagonist |
| citrinin | [no description available] | medium | 1 | 0 | ||
| vulpinic acid | [no description available] | medium | 1 | 0 | butenolide | |
| ajmaline | [no description available] | medium | 1 | 0 | ||
| rifampin | [no description available] | medium | 1 | 0 | cyclic ketal; hydrazone; N-iminopiperazine; N-methylpiperazine; rifamycins; semisynthetic derivative; zwitterion | angiogenesis inhibitor; antiamoebic agent; antineoplastic agent; antitubercular agent; DNA synthesis inhibitor; EC 2.7.7.6 (RNA polymerase) inhibitor; Escherichia coli metabolite; geroprotector; leprostatic drug; neuroprotective agent; pregnane X receptor agonist; protein synthesis inhibitor |
| alpha-cyclopiazonic acid | [no description available] | medium | 1 | 0 | alpha-cyclopiazonic acids | |
| ofloxacin | [no description available] | medium | 1 | 0 | 3-oxo monocarboxylic acid; N-arylpiperazine; N-methylpiperazine; organofluorine compound; oxazinoquinoline | |
| episesamin | [no description available] | medium | 1 | 0 | ||
| caryophyllene oxide | [no description available] | medium | 1 | 0 | epoxide | metabolite |
| manool | [no description available] | medium | 1 | 0 | labdane diterpenoid; tertiary alcohol | antibacterial agent; antineoplastic agent; plant metabolite |
| apigetrin | [no description available] | medium | 1 | 0 | beta-D-glucoside; dihydroxyflavone; glycosyloxyflavone; monosaccharide derivative | antibacterial agent; metabolite; non-steroidal anti-inflammatory drug |
| acridines | [no description available] | medium | 2 | 0 | acridines; mancude organic heterotricyclic parent; polycyclic heteroarene | genotoxin |
| ammonium hydroxide | [no description available] | medium | 1 | 0 | azane; gas molecular entity; mononuclear parent hydride | EC 3.5.1.4 (amidase) inhibitor; metabolite; mouse metabolite; neurotoxin; NMR chemical shift reference compound; nucleophilic reagent; refrigerant |
| carbostyril | [no description available] | medium | 2 | 0 | monohydroxyquinoline; quinolone | bacterial xenobiotic metabolite |
| arborinine | [no description available] | medium | 1 | 0 | acridines | |
| diuron | [no description available] | medium | 1 | 0 | 3-(3,4-substituted-phenyl)-1,1-dimethylurea; dichlorobenzene | environmental contaminant; mitochondrial respiratory-chain inhibitor; photosystem-II inhibitor; urea herbicide; xenobiotic |
| stigmasterol | [no description available] | medium | 1 | 0 | 3beta-hydroxy-Delta(5)-steroid; 3beta-sterol; phytosterols; stigmastane sterol | plant metabolite |
| gamma-sitosterol | [no description available] | medium | 1 | 0 | 3beta-hydroxy-Delta(5)-steroid; 3beta-sterol; phytosterols | marine metabolite; plant metabolite |
| cytellin | [no description available] | medium | 1 | 0 | ||
| adenine | [no description available] | medium | 1 | 0 | 6-aminopurines; purine nucleobase | Daphnia magna metabolite; Escherichia coli metabolite; human metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite |
| 3-methyladenine | [no description available] | medium | 1 | 0 | ||
| 5,7-dichlorokynurenic acid | [no description available] | low | 0 | 0 | quinolines | |
| broxyquinoline | [no description available] | low | 0 | 0 | organohalogen compound; quinolines | |
| bu 224 | [no description available] | low | 0 | 0 | quinolines | |
| cilostamide | [no description available] | low | 0 | 0 | quinolines | |
| cloxyquin | [no description available] | low | 0 | 0 | organochlorine compound; quinolines | |
| ethoxyquin | [no description available] | low | 0 | 0 | aromatic ether; quinolines | antifungal agrochemical; food antioxidant; genotoxin; geroprotector; herbicide; Hsp90 inhibitor; neuroprotective agent; UDP-glucuronosyltransferase activator |
| fleroxacin | [no description available] | low | 0 | 0 | difluorobenzene; fluoroquinolone antibiotic; monocarboxylic acid; N-alkylpiperazine; quinolines | antibacterial drug; EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor; topoisomerase IV inhibitor |
| mefloquine hydrochloride | [no description available] | low | 0 | 0 | organofluorine compound; piperidines; quinolines; secondary alcohol | |
| oxamniquine | [no description available] | low | 0 | 0 | aromatic primary alcohol; C-nitro compound; quinolines; secondary amino compound | |
| procaterol | [no description available] | low | 0 | 0 | quinolines | |
| 6-nitroquipazine | [no description available] | low | 0 | 0 | nitro compound; quinolines | |
| pf 5901 | [no description available] | low | 0 | 0 | quinolines | |
| quinophthalone | [no description available] | low | 0 | 0 | aromatic ketone; beta-diketone; quinolines | dye |
| echinopsine | [no description available] | low | 0 | 0 | quinolines | |
| dimoxyline | [no description available] | low | 0 | 0 | quinolines | |
| quinoline | [no description available] | low | 0 | 0 | azaarene; mancude organic heterobicyclic parent; ortho-fused heteroarene; quinolines | |
| 6-methylquinoline | [no description available] | low | 0 | 0 | quinolines | |
| 2-methylquinoline | [no description available] | low | 0 | 0 | quinolines | |
| cinchophen | [no description available] | low | 0 | 0 | quinolines | |
| oxycinchophen | [no description available] | low | 0 | 0 | quinolines | |
| 6-methoxyquinoline | [no description available] | low | 0 | 0 | aromatic ether; quinolines | |
| actinoquinol | [no description available] | low | 0 | 0 | quinolines | |
| nequinate | [no description available] | low | 0 | 0 | quinolines | |
| miloxacin | [no description available] | low | 0 | 0 | quinolines | |
| amifloxacin | [no description available] | low | 0 | 0 | quinolines | |
| sarafloxacin | [no description available] | low | 0 | 0 | quinolines | |
| rufloxacin | [no description available] | low | 0 | 0 | fluoroquinolone antibiotic; quinolines; quinolone antibiotic | |
| clinafloxacin | [no description available] | low | 0 | 0 | quinolines | |
| orbifloxacin | [no description available] | low | 0 | 0 | quinolines | |
| marbofloxacin | [no description available] | low | 0 | 0 | quinolines | |
| toborinone | [no description available] | low | 0 | 0 | quinolines | |
| 3,4-dihydro-2(1h)-quinolinone | [no description available] | low | 0 | 0 | quinolines | |
| tilbroquinol | [no description available] | low | 0 | 0 | organohalogen compound; quinolines | |
| pazufloxacin | [no description available] | low | 0 | 0 | quinolines | |
| 7-(trifluoromethyl)-1H-quinolin-4-one | [no description available] | low | 0 | 0 | quinolines | |
| 2-Methyl-4-quinolinol | [no description available] | low | 0 | 0 | quinolines | |
| 1,2,3,4-tetrahydroquinoline | [no description available] | low | 0 | 0 | quinolines | |
| danofloxacin | [no description available] | low | 0 | 0 | quinolines | |
| premafloxacin | [no description available] | low | 0 | 0 | quinolines | |
| quinfamide | [no description available] | low | 0 | 0 | quinolines | |
| grepafloxacin | [no description available] | low | 0 | 0 | fluoroquinolone antibiotic; quinolines; quinolone antibiotic | |
| 8-hydroxy-2-quinolinecarboxylic acid | [no description available] | low | 0 | 0 | quinolines | |
| 8-(trifluoromethyl)-1H-quinolin-4-one | [no description available] | low | 0 | 0 | quinolines | |
| cloquintocet-mexyl | [no description available] | low | 0 | 0 | aromatic ether; carboxylic ester; organochlorine compound; quinolines | |
| 2-hydroxyamino-3-methylimidazolo(4,5-f)quinoline | [no description available] | low | 0 | 0 | quinolines | |
| ulifloxacin | [no description available] | low | 0 | 0 | quinolines | |
| 8-hydroxycarteolol | [no description available] | low | 0 | 0 | quinolines | |
| 3-(4-carboxybenzoyl)-2-quinolinecarboxaldehyde | [no description available] | low | 0 | 0 | benzoic acids; quinolines | fluorochrome |
| sr 2640 | [no description available] | low | 0 | 0 | quinolines | |
| a 195773 | [no description available] | low | 0 | 0 | macrolide antibiotic; monosaccharide derivative; quinolines | antibacterial drug; protein synthesis inhibitor |
| torcetrapib | [no description available] | low | 0 | 0 | (trifluoromethyl)benzenes; carbamate ester; quinolines | anticholesteremic drug; CETP inhibitor |
| mefloquine carboxylic acid | [no description available] | low | 0 | 0 | quinolines | |
| 6-Methoxyquinoline N-oxide | [no description available] | low | 0 | 0 | quinolines | |
| 1-[(4-methoxyphenyl)-oxomethyl]-2H-quinoline-2-carbonitrile | [no description available] | low | 0 | 0 | quinolines | |
| 2-quinolinecarboxylic acid (4-nitrophenyl) ester | [no description available] | low | 0 | 0 | quinolines | |
| 3-nitro-1H-quinolin-4-one | [no description available] | low | 0 | 0 | nitro compound; quinolines | |
| Dubamine | [no description available] | low | 0 | 0 | quinolines | |
| saquinavir | [no description available] | low | 0 | 0 | L-asparagine derivative; quinolines | antiviral drug; HIV protease inhibitor |
| bms 195614 | [no description available] | low | 0 | 0 | benzoic acids; quinolines; secondary carboxamide | retinoic acid receptor alpha antagonist |
| hts 466284 | [no description available] | low | 0 | 0 | pyrazoles; pyridines; quinolines | TGFbeta receptor antagonist |
| 5-carboxy-8-hydroxyquinoline | [no description available] | low | 0 | 0 | quinolines | |
| sitafloxacin | [no description available] | low | 0 | 0 | fluoroquinolone antibiotic; quinolines; quinolone antibiotic | |
| 8-prop-2-enylsulfonylquinoline | [no description available] | low | 0 | 0 | quinolines | |
| 2-amino-3-cyano-5,6,7,8-tetrahydroquinoline-4-carboxylic acid methyl ester | [no description available] | low | 0 | 0 | quinolines | |
| 3-[[cyclopentyl-[[1-(phenylmethyl)-5-tetrazolyl]methyl]amino]methyl]-8-methyl-1H-quinolin-2-one | [no description available] | low | 0 | 0 | quinolines | |
| N-[(8-methyl-2-oxo-1H-quinolin-3-yl)methyl]-N-(2-oxolanylmethyl)-2-furancarboxamide | [no description available] | low | 0 | 0 | quinolines | |
| 3-[(1-cyclopentyl-5-tetrazolyl)-(3,4-dihydro-1H-isoquinolin-2-yl)methyl]-7-methoxy-1H-quinolin-2-one | [no description available] | low | 0 | 0 | quinolines | |
| 3-[[1,3-benzodioxol-5-ylmethyl-[[1-(2-furanylmethyl)-5-tetrazolyl]methyl]amino]methyl]-6-methyl-1H-quinolin-2-one | [no description available] | low | 0 | 0 | quinolines | |
| 1-[3-(dimethylamino)propyl]-3-(4-fluorophenyl)-1-[(6-methoxy-2-oxo-1H-quinolin-3-yl)methyl]urea | [no description available] | low | 0 | 0 | quinolines | |
| 1-[3-(dimethylamino)propyl]-1-[(6-methoxy-2-oxo-1H-quinolin-3-yl)methyl]-3-phenylurea | [no description available] | low | 0 | 0 | quinolines | |
| 6-[[4-(1,3-benzodioxol-5-ylmethyl)-1-piperazinyl]-[1-(2-methylbutan-2-yl)-5-tetrazolyl]methyl]quinoline | [no description available] | low | 0 | 0 | quinolines | |
| 3-[(1-tert-butyl-5-tetrazolyl)-[2-furanylmethyl(2-oxolanylmethyl)amino]methyl]-6-methoxy-1H-quinolin-2-one | [no description available] | low | 0 | 0 | quinolines | |
| 3-[[1,3-benzodioxol-5-ylmethyl-[(1-cyclopentyl-5-tetrazolyl)methyl]amino]methyl]-6-ethyl-1H-quinolin-2-one | [no description available] | low | 0 | 0 | quinolines | |
| 6-ethyl-3-[[[1-(2-furanylmethyl)-5-tetrazolyl]methyl-(phenylmethyl)amino]methyl]-1H-quinolin-2-one | [no description available] | low | 0 | 0 | quinolines | |
| N-(2-hydroxyethyl)-5-methyl-N-[(7-oxo-3,6-dihydro-2H-[1,4]dioxino[2,3-g]quinolin-8-yl)methyl]-2,1,3-benzothiadiazole-4-sulfonamide | [no description available] | low | 0 | 0 | quinolines | |
| 3-[[[1-[1-(2-furanylmethyl)-5-tetrazolyl]-2-methylpropyl]-(2-oxolanylmethyl)amino]methyl]-8-methyl-1H-quinolin-2-one | [no description available] | low | 0 | 0 | quinolines | |
| 6,8-dimethyl-3-[(3-methyl-1-piperidinyl)-[1-(2-oxolanylmethyl)-5-tetrazolyl]methyl]-1H-quinolin-2-one | [no description available] | low | 0 | 0 | quinolines | |
| 1-[3-(4-morpholinyl)propyl]-1-[(7-oxo-3,6-dihydro-2H-[1,4]dioxino[2,3-g]quinolin-8-yl)methyl]-3-phenylurea | [no description available] | low | 0 | 0 | quinolines | |
| 6-methyl-3-[[[1-(phenylmethyl)-5-tetrazolyl]methyl-(thiophen-2-ylmethyl)amino]methyl]-1H-quinolin-2-one | [no description available] | low | 0 | 0 | quinolines | |
| N-[(6-ethoxy-2-oxo-1H-quinolin-3-yl)methyl]-4-fluoro-N-(2-hydroxyethyl)benzamide | [no description available] | low | 0 | 0 | quinolines | |
| 6-ethoxy-3-[[2-oxolanylmethyl-[[1-(2-phenylethyl)-5-tetrazolyl]methyl]amino]methyl]-1H-quinolin-2-one | [no description available] | low | 0 | 0 | quinolines | |
| 1-[(7,8-dimethyl-2-oxo-1H-quinolin-3-yl)methyl]-1-[(1-ethyl-2-pyrrolidinyl)methyl]-3-(2-methoxyphenyl)urea | [no description available] | low | 0 | 0 | quinolines | |
| 3-[1-azepanyl-[1-(phenylmethyl)-5-tetrazolyl]methyl]-7-methoxy-1H-quinolin-2-one | [no description available] | low | 0 | 0 | quinolines | |
| 3-[[[1-(2-furanylmethyl)-5-tetrazolyl]methyl-[(2-methoxyphenyl)methyl]amino]methyl]-6-methyl-1H-quinolin-2-one | [no description available] | low | 0 | 0 | quinolines | |
| 7-[[1-(2-oxolanylmethyl)-5-tetrazolyl]-(1-pyrrolidinyl)methyl]-5H-[1,3]dioxolo[4,5-g]quinolin-6-one | [no description available] | low | 0 | 0 | quinolines | |
| 1-(1,3-benzodioxol-5-ylmethyl)-3-(4-methylphenyl)-1-[(7-oxo-3,6-dihydro-2H-[1,4]dioxino[2,3-g]quinolin-8-yl)methyl]urea | [no description available] | low | 0 | 0 | quinolines | |
| N-[(7-methoxy-2-oxo-1H-quinolin-3-yl)methyl]-N-(3-pyridinylmethyl)benzenesulfonamide | [no description available] | low | 0 | 0 | quinolines | |
| 1-[(1-tert-butyl-5-tetrazolyl)-thiophen-2-ylmethyl]-3,4-dihydro-2H-quinoline | [no description available] | low | 0 | 0 | quinolines | |
| 2-[(3-ethyl-2-quinolinyl)thio]-N-(5-methyl-3-isoxazolyl)acetamide | [no description available] | low | 0 | 0 | quinolines | |
| 3-cyclohexyl-1-[(7-oxo-3,6-dihydro-2H-[1,4]dioxino[2,3-g]quinolin-8-yl)methyl]-1-[2-(1-pyrrolidinyl)ethyl]urea | [no description available] | low | 0 | 0 | quinolines | |
| 1-[(6-methoxy-2-oxo-1H-quinolin-3-yl)methyl]-3-(4-methoxyphenyl)-1-(2-oxolanylmethyl)urea | [no description available] | low | 0 | 0 | quinolines | |
| 3-[3,4,6,7,8,8a-hexahydro-1H-pyrrolo[1,2-a]pyrazin-2-yl-[1-(2-oxolanylmethyl)-5-tetrazolyl]methyl]-6-ethyl-1H-quinolin-2-one | [no description available] | low | 0 | 0 | quinolines | |
| N-[(6-methoxy-2-oxo-1H-quinolin-3-yl)methyl]-N-(2-methylphenyl)propanamide | [no description available] | low | 0 | 0 | quinolines | |
| 3-[[[1-[(4-fluorophenyl)methyl]-5-tetrazolyl]methyl-(2-hydroxyethyl)amino]methyl]-7-methyl-1H-quinolin-2-one | [no description available] | low | 0 | 0 | quinolines | |
| 1-[2-(dimethylamino)ethyl]-1-[(6-methoxy-2-oxo-1H-quinolin-3-yl)methyl]-3-(phenylmethyl)urea | [no description available] | low | 0 | 0 | quinolines | |
| 2-[[2-(1-azepanyl)-2-oxoethyl]thio]-6-methoxy-3-quinolinecarbonitrile | [no description available] | low | 0 | 0 | quinolines | |
| 6-methoxy-3-[[2-oxolanylmethyl-[1-[1-(phenylmethyl)-5-tetrazolyl]propyl]amino]methyl]-1H-quinolin-2-one | [no description available] | low | 0 | 0 | quinolines | |
| 3-[2-hydroxyethyl-[(6-methoxy-2-oxo-1H-quinolin-3-yl)methyl]sulfamoyl]benzoic acid ethyl ester | [no description available] | low | 0 | 0 | quinolines | |
| 3-(3-chlorophenyl)-1-(3-hydroxypropyl)-1-[(8-methyl-2-oxo-1H-quinolin-3-yl)methyl]urea | [no description available] | low | 0 | 0 | quinolines | |
| 6-methoxy-3-[[[1-(2-methoxyethyl)-5-tetrazolyl]methyl-(3-pyridinylmethyl)amino]methyl]-1H-quinolin-2-one | [no description available] | low | 0 | 0 | quinolines | |
| 4-bromo-N-[(6-ethoxy-2-oxo-1H-quinolin-3-yl)methyl]-N-(2-hydroxyethyl)benzamide | [no description available] | low | 0 | 0 | quinolines | |
| 6-ethoxy-3-[[[1-(2-methylbutan-2-yl)-5-tetrazolyl]methyl-(thiophen-2-ylmethyl)amino]methyl]-1H-quinolin-2-one | [no description available] | low | 0 | 0 | quinolines | |
| 3-[3,4-dihydro-1H-isoquinolin-2-yl-[1-(2-methylbutan-2-yl)-5-tetrazolyl]methyl]-7-methoxy-1H-quinolin-2-one | [no description available] | low | 0 | 0 | quinolines | |
| 1-[3-(dimethylamino)propyl]-1-[(5,8-dimethyl-2-oxo-1H-quinolin-3-yl)methyl]-3-(phenylmethyl)urea | [no description available] | low | 0 | 0 | quinolines | |
| 3-(2-chlorophenyl)-1-[(6-methoxy-2-oxo-1H-quinolin-3-yl)methyl]-1-[2-(1-pyrrolidinyl)ethyl]urea | [no description available] | low | 0 | 0 | quinolines | |
| 8-[(1-tert-butyl-5-tetrazolyl)-thiomorpholin-4-ylmethyl]-3,6-dihydro-2H-[1,4]dioxino[2,3-g]quinolin-7-one | [no description available] | low | 0 | 0 | quinolines | |
| 1-cyclopentyl-1-[(7-methoxy-2-oxo-1H-quinolin-3-yl)methyl]-3-(2-methoxyphenyl)urea | [no description available] | low | 0 | 0 | quinolines | |
| 3-[3,4-dihydro-1H-isoquinolin-2-yl-[1-(2-oxolanylmethyl)-5-tetrazolyl]methyl]-6-methyl-1H-quinolin-2-one | [no description available] | low | 0 | 0 | quinolines | |
| 2-fluoro-N-(2-hydroxyethyl)-N-[(6-methoxy-2-oxo-1H-quinolin-3-yl)methyl]benzamide | [no description available] | low | 0 | 0 | quinolines | |
| 3-[[(1-tert-butyl-5-tetrazolyl)methyl-(thiophen-2-ylmethyl)amino]methyl]-6-ethoxy-1H-quinolin-2-one | [no description available] | low | 0 | 0 | quinolines | |
| 6-ethoxy-3-[[2-furanylmethyl-[[1-(phenylmethyl)-5-tetrazolyl]methyl]amino]methyl]-1H-quinolin-2-one | [no description available] | low | 0 | 0 | quinolines | |
| 3-[1-azepanyl-[1-[(4-fluorophenyl)methyl]-5-tetrazolyl]methyl]-6,7-dimethoxy-1H-quinolin-2-one | [no description available] | low | 0 | 0 | quinolines | |
| N-(2-furanylmethyl)-N-[(6-methoxy-2-oxo-1H-quinolin-3-yl)methyl]benzamide | [no description available] | low | 0 | 0 | quinolines | |
| N-[(6,7-dimethoxy-2-oxo-1H-quinolin-3-yl)methyl]-N-(3-hydroxypropyl)benzenesulfonamide | [no description available] | low | 0 | 0 | quinolines | |
| 6-methoxy-3-[[2-oxolanylmethyl-[[1-(phenylmethyl)-5-tetrazolyl]methyl]amino]methyl]-1H-quinolin-2-one | [no description available] | low | 0 | 0 | quinolines | |
| 1-[(6,7-dimethoxy-2-oxo-1H-quinolin-3-yl)methyl]-3-(phenylmethyl)-1-(3-pyridinylmethyl)urea | [no description available] | low | 0 | 0 | quinolines | |
| 4-[2-(3,4-dihydro-2H-quinolin-1-yl)-2-oxoethyl]-5-furo[3,2-b]pyrrolecarboxylic acid ethyl ester | [no description available] | low | 0 | 0 | quinolines | |
| 4-methyl-6-(methylthio)-1H-quinolin-2-one | [no description available] | low | 0 | 0 | quinolines | |
| 2-[(3-cyano-5,7-dimethyl-2-quinolinyl)thio]-N-(2-furanylmethyl)acetamide | [no description available] | low | 0 | 0 | quinolines | |
| 3-[[cyclopentyl-[[1-[(4-methoxyphenyl)methyl]-5-tetrazolyl]methyl]amino]methyl]-7-methyl-1H-quinolin-2-one | [no description available] | low | 0 | 0 | quinolines | |
| 3-cyclohexyl-1-[(6,7-dimethyl-2-oxo-1H-quinolin-3-yl)methyl]-1-[3-(4-morpholinyl)propyl]urea | [no description available] | low | 0 | 0 | quinolines | |
| 3-[[1-(1,3-benzodioxol-5-ylmethyl)-5-tetrazolyl]-(1-pyrrolidinyl)methyl]-8-methyl-1H-quinolin-2-one | [no description available] | low | 0 | 0 | quinolines | |
| 3-[[1-[1-(2-furanylmethyl)-5-tetrazolyl]propyl-(2-phenylethyl)amino]methyl]-7-methoxy-1H-quinolin-2-one | [no description available] | low | 0 | 0 | quinolines | |
| 1-[(5,8-dimethyl-2-oxo-1H-quinolin-3-yl)methyl]-1-(2-furanylmethyl)-3-phenylurea | [no description available] | low | 0 | 0 | quinolines | |
| N-(2-furanylmethyl)-N-[(7-methyl-4-tetrazolo[1,5-a]quinolinyl)methyl]-2-phenoxyacetamide | [no description available] | low | 0 | 0 | quinolines | |
| 9-oxo-N-(3-pyridinylmethyl)-3,6-dihydro-2H-[1,4]dioxino[2,3-g]quinoline-8-carboxamide | [no description available] | low | 0 | 0 | aromatic amide; quinolines | |
| (6-fluoro-2-methyl-3,4-dihydro-2H-quinolin-1-yl)-[5-(2-furanyl)-7-(trifluoromethyl)-2-pyrazolo[1,5-a]pyrimidinyl]methanone | [no description available] | low | 0 | 0 | quinolines | |
| 6-methoxy-3-[[[1-(2-oxolanylmethyl)-5-tetrazolyl]methyl-(2-phenylethyl)amino]methyl]-1H-quinolin-2-one | [no description available] | low | 0 | 0 | quinolines | |
| N-[(6-methoxy-2-oxo-1H-quinolin-3-yl)methyl]-N-(thiophen-2-ylmethyl)-2,1,3-benzothiadiazole-4-sulfonamide | [no description available] | low | 0 | 0 | quinolines | |
| 1-piperidinecarboxylic acid (5-chloro-8-quinolinyl) ester | [no description available] | low | 0 | 0 | organochlorine compound; quinolines | |
| N-[(5,8-dimethyl-2-oxo-1H-quinolin-3-yl)methyl]-4-methoxy-N-[3-(2-oxo-1-pyrrolidinyl)propyl]benzenesulfonamide | [no description available] | low | 0 | 0 | quinolines | |
| 4-chloro-N-[(7-oxo-3,6-dihydro-2H-[1,4]dioxino[2,3-g]quinolin-8-yl)methyl]-N-(2-oxolanylmethyl)benzenesulfonamide | [no description available] | low | 0 | 0 | quinolines | |
| 3-[3,4,6,7,8,8a-hexahydro-1H-pyrrolo[1,2-a]pyrazin-2-yl-[1-(2-oxolanylmethyl)-5-tetrazolyl]methyl]-5,7-dimethyl-1H-quinolin-2-one | [no description available] | low | 0 | 0 | quinolines | |
| 2-[[3-cyano-4-(5-methyl-2-furanyl)-5,6,7,8-tetrahydroquinolin-2-yl]thio]acetic acid methyl ester | [no description available] | low | 0 | 0 | quinolines | |
| N-[(2R,4S)-2-methyl-1-(1-oxopropyl)-3,4-dihydro-2H-quinolin-4-yl]-N-phenylacetamide | [no description available] | low | 0 | 0 | quinolines | |
| 1-ethyl-6-methoxy-4-oxo-3-quinolinecarboxylic acid | [no description available] | low | 0 | 0 | quinolines | |
| 2-[[3-cyano-4-(2-furanyl)-5,6,7,8-tetrahydroquinolin-2-yl]thio]-N-(2-methylphenyl)acetamide | [no description available] | low | 0 | 0 | quinolines | |
| 2-(6-bromo-2-methyl-4-oxo-1-quinolinyl)-N-(2-methoxyphenyl)acetamide | [no description available] | low | 0 | 0 | quinolines | |
| 3-methyl-N-(1-propyl-3-pyrazolo[3,4-b]quinolinyl)butanamide | [no description available] | low | 0 | 0 | quinolines | |
| N-(1-propyl-3-pyrazolo[3,4-b]quinolinyl)butanamide | [no description available] | low | 0 | 0 | quinolines | |
| 3-[(4-methoxyanilino)methyl]-1H-quinolin-2-one | [no description available] | low | 0 | 0 | quinolines | |
| N-[(6-methoxy-2-oxo-1H-quinolin-3-yl)methyl]-N-methyl-4-pyridinecarboxamide | [no description available] | low | 0 | 0 | quinolines | |
| 3-(ethylaminomethyl)-6-methyl-1H-quinolin-2-one | [no description available] | low | 0 | 0 | quinolines | |
| N-(1,8-dimethyl-3-pyrazolo[3,4-b]quinolinyl)propanamide | [no description available] | low | 0 | 0 | quinolines | |
| 2-methoxy-N-[(6-methoxy-2-oxo-1H-quinolin-3-yl)methyl]-N-(2-methoxyphenyl)acetamide | [no description available] | low | 0 | 0 | quinolines | |
| 2,3-dihydroindol-1-yl-(6-fluoro-2-methyl-4-quinolinyl)methanone | [no description available] | low | 0 | 0 | quinolines | |
| N-(1-ethyl-7-methyl-3-pyrazolo[3,4-b]quinolinyl)-2-furancarboxamide | [no description available] | low | 0 | 0 | quinolines | |
| N-[(6-methoxy-2-oxo-1H-quinolin-3-yl)methyl]-N-(4-methylphenyl)-2-oxolanecarboxamide | [no description available] | low | 0 | 0 | quinolines | |
| N-[(7-methyl-2-oxo-1H-quinolin-3-yl)methyl]-N-propan-2-yl-4-pyridinecarboxamide | [no description available] | low | 0 | 0 | quinolines | |
| N-[(7-methyl-2-oxo-1H-quinolin-3-yl)methyl]-N-propyl-2-pyridinecarboxamide | [no description available] | low | 0 | 0 | quinolines | |
| N-butyl-N-[(6-methoxy-2-oxo-1H-quinolin-3-yl)methyl]-2-pyridinecarboxamide | [no description available] | low | 0 | 0 | quinolines | |
| N-(1,7-dimethyl-3-pyrazolo[3,4-b]quinolinyl)acetamide | [no description available] | low | 0 | 0 | quinolines | |
| N-(1-ethyl-6-methyl-3-pyrazolo[3,4-b]quinolinyl)-4-pyridinecarboxamide | [no description available] | low | 0 | 0 | quinolines | |
| N-(2-furanylmethyl)-N-[(8-methyl-2-oxo-1H-quinolin-3-yl)methyl]-2-thiophenecarboxamide | [no description available] | low | 0 | 0 | quinolines | |
| 5-(1-imidazolylsulfonyl)-8-methoxyquinoline | [no description available] | low | 0 | 0 | quinolines | |
| 2-amino-4-(5-methyl-2-furanyl)-5,6,7,8-tetrahydroquinoline-3-carbonitrile | [no description available] | low | 0 | 0 | quinolines | |
| 2-(8-quinolinylthio)acetic acid | [no description available] | low | 0 | 0 | quinolines | |
| 4-chloro-1-methyl-3-nitro-2-quinolinone | [no description available] | low | 0 | 0 | nitro compound; quinolines | |
| 4-(1H-benzimidazol-2-yl)quinoline | [no description available] | low | 0 | 0 | quinolines | |
| 3-[(4,8-dimethyl-2-quinolinyl)thio]propanoic acid | [no description available] | low | 0 | 0 | quinolines | |
| 3-pyridinecarboxylic acid (5-chloro-8-quinolinyl) ester | [no description available] | low | 0 | 0 | organochlorine compound; quinolines | |
| 2-amino-4-thiophen-2-yl-5,6,7,8-tetrahydroquinoline-3-carbonitrile | [no description available] | low | 0 | 0 | quinolines | |
| 2,2,2-trifluoro-N-(2-methyl-8-quinolinyl)acetamide | [no description available] | low | 0 | 0 | quinolines; secondary carboxamide; trifluoroacetamide | |
| 8-(3,5-dimethyl-1-pyrazolyl)quinoline | [no description available] | low | 0 | 0 | quinolines | |
| 1-methyl-4-[(4-methylphenyl)thio]-3-nitro-2-quinolinone | [no description available] | low | 0 | 0 | nitro compound; quinolines | |
| 4-chloro-2-methyl-3-(3-oxobutyl)-6-quinolinecarboxylic acid | [no description available] | low | 0 | 0 | quinolines | |
| 4-chloro-1-ethyl-3-nitro-2-quinolinone | [no description available] | low | 0 | 0 | nitro compound; quinolines | |
| 4-chloro-3-nitro-1-(phenylmethyl)-2-quinolinone | [no description available] | low | 0 | 0 | quinolines | |
| 6-(1,4,5,7-tetramethyl-6-pyrrolo[3,4-d]pyridazinyl)quinoline | [no description available] | low | 0 | 0 | quinolines | |
| N-[[(2,4-dimethyl-8-quinolinyl)amino]-sulfanylidenemethyl]-4-methylbenzamide | [no description available] | low | 0 | 0 | quinolines | |
| 4,7-dimethoxy-1-methyl-2-quinolinone | [no description available] | low | 0 | 0 | quinolines | |
| N-[3,4-dihydro-2H-quinolin-1-yl(sulfanylidene)methyl]-2-(3-methylphenoxy)acetamide | [no description available] | low | 0 | 0 | quinolines | |
| 2-[(7-ethyl-[1,3]dioxolo[4,5-g]quinolin-6-yl)thio]acetic acid propan-2-yl ester | [no description available] | low | 0 | 0 | quinolines | |
| N-cyclopentyl-2-[(6-methoxy-3-methyl-2-quinolinyl)thio]acetamide | [no description available] | low | 0 | 0 | quinolines | |
| 4-(4-morpholinylmethyl)-3-quinolinol | [no description available] | low | 0 | 0 | quinolines | |
| N-(4-hydroxyphenyl)-8-quinolinesulfonamide | [no description available] | low | 0 | 0 | quinolines | |
| [2-(5-methyl-2-thiophenyl)-4-quinolinyl]-(1-pyrrolidinyl)methanone | [no description available] | low | 0 | 0 | quinolines | |
| 2-thiophenecarboxylic acid (6-methyl-2-oxo-1H-quinolin-3-yl)methyl ester | [no description available] | low | 0 | 0 | quinolines | |
| N-[6-methyl-1-(2-methylpropyl)-3-pyrazolo[3,4-b]quinolinyl]-2-furancarboxamide | [no description available] | low | 0 | 0 | quinolines | |
| 3-[(6-methoxy-4-methyl-2-quinolinyl)thio]propanoic acid | [no description available] | low | 0 | 0 | quinolines | |
| 6-methoxy-3-[(3-methylanilino)methyl]-1H-quinolin-2-one | [no description available] | low | 0 | 0 | quinolines | |
| 3-[(2,5-dimethylanilino)methyl]-6-methoxy-1H-quinolin-2-one | [no description available] | low | 0 | 0 | quinolines | |
| N-(5-quinolinyl)-2-benzofurancarboxamide | [no description available] | low | 0 | 0 | quinolines | |
| 1-(1-pyrrolidinyl)-2-(8-quinolinylthio)ethanone | [no description available] | low | 0 | 0 | quinolines | |
| N-(5-bromo-8-quinolinyl)-5-[(4-chloro-1-pyrazolyl)methyl]-2-furancarboxamide | [no description available] | low | 0 | 0 | organohalogen compound; quinolines | |
| 1-[[[2-(2,4-dichlorophenyl)-4-quinolinyl]-oxomethyl]amino]-3-phenylurea | [no description available] | low | 0 | 0 | quinolines | |
| 2-[9-(4-methoxyphenyl)-1,8-dioxo-3,4,5,6,7,9-hexahydro-2H-acridin-10-yl]acetic acid | [no description available] | low | 0 | 0 | quinolines | |
| 2-(3-bromophenyl)-N-(4,5-dihydrothiazol-2-yl)-4-quinolinecarboxamide | [no description available] | low | 0 | 0 | quinolines | |
| 6-chloro-4-phenyl-3-(1-phenyl-5-tetrazolyl)quinoline | [no description available] | low | 0 | 0 | quinolines | |
| 2-[3-(4-methoxyphenyl)-1-benzo[f]quinolinyl]acetic acid ethyl ester | [no description available] | low | 0 | 0 | quinolines | |
| [3-bromo-5-thiophen-2-yl-7-(trifluoromethyl)-2-pyrazolo[1,5-a]pyrimidinyl]-(3,4-dihydro-2H-quinolin-1-yl)methanone | [no description available] | low | 0 | 0 | quinolines | |
| 2-[2-oxo-2-(2,2,4,6-tetramethyl-1-quinolinyl)ethyl]isoindole-1,3-dione | [no description available] | low | 0 | 0 | quinolines | |
| 6-bromo-3-(4-morpholinyl)-4-phenyl-1H-quinolin-2-one | [no description available] | low | 0 | 0 | quinolines | |
| 7-chloro-2,3-dihydro-1H-cyclopenta[b]quinoline-9-carboxylic acid | [no description available] | low | 0 | 0 | quinolines | |
| 6-ethyl-2-thieno[2,3-b]quinolinecarboxylic acid | [no description available] | low | 0 | 0 | quinolines | |
| N-[4-[(4-methyl-1-piperidinyl)sulfonyl]phenyl]-2-[(4-methyl-[1,2,4]triazolo[4,3-a]quinolin-1-yl)thio]acetamide | [no description available] | low | 0 | 0 | quinolines | |
| 2-[(7-methoxy-4-methyl-[1,2,4]triazolo[4,3-a]quinolin-1-yl)thio]-N-methyl-N-(4-phenyl-2-thiazolyl)acetamide | [no description available] | low | 0 | 0 | quinolines | |
| 1-cyclopentyl-1-[(5,8-dimethyl-2-oxo-1H-quinolin-3-yl)methyl]-3-ethylthiourea | [no description available] | low | 0 | 0 | quinolines | |
| 2-[[[1,3-benzodioxol-5-ylmethyl-[(6-methyl-2-oxo-1H-quinolin-3-yl)methyl]amino]-sulfanylidenemethyl]amino]benzoic acid methyl ester | [no description available] | low | 0 | 0 | quinolines | |
| 3-(4-ethoxyphenyl)-1-[2-(4-morpholinyl)ethyl]-1-[(7-oxo-3,6-dihydro-2H-[1,4]dioxino[2,3-g]quinolin-8-yl)methyl]thiourea | [no description available] | low | 0 | 0 | quinolines | |
| 1-[(6,7-dimethoxy-2-oxo-1H-quinolin-3-yl)methyl]-3-methyl-1-(thiophen-2-ylmethyl)thiourea | [no description available] | low | 0 | 0 | quinolines | |
| 2-[9-(3-chloro-4-methoxyphenyl)-1,8-dioxo-3,4,5,6,7,9-hexahydro-2H-acridin-10-yl]acetic acid | [no description available] | low | 0 | 0 | quinolines | |
| N-[(6-chloro-2-oxo-4-phenyl-1H-quinolin-3-yl)methyl]-4-methylbenzenesulfonamide | [no description available] | low | 0 | 0 | quinolines | |
| N-(2,6-dimethylphenyl)-2-[(6-methoxy-2-methyl-4-quinolinyl)thio]acetamide | [no description available] | low | 0 | 0 | quinolines | |
| 2-[(3-cyano-6-methoxy-2-quinolinyl)thio]-N-(2-methyl-1,3-benzothiazol-5-yl)acetamide | [no description available] | low | 0 | 0 | quinolines | |
| 1-(6-methoxy-2,2,4-trimethyl-1-quinolinyl)-2-[[5-(4-methylphenyl)-1,3,4-oxadiazol-2-yl]thio]ethanone | [no description available] | low | 0 | 0 | quinolines | |
| 1-[(7,8-dimethyl-2-oxo-1H-quinolin-3-yl)methyl]-1-(2-furanylmethyl)-3-(2-methoxyphenyl)thiourea | [no description available] | low | 0 | 0 | quinolines | |
| 10-(4-methoxyphenyl)-3,4,5,6,7,9-hexahydro-2H-acridine-1,8-dione | [no description available] | low | 0 | 0 | quinolines | |
| 3-[[[2-(3-methylphenyl)-4-quinolinyl]-oxomethyl]amino]-2-thiophenecarboxylic acid methyl ester | [no description available] | low | 0 | 0 | quinolines | |
| 1-benzimidazolyl-[2-(4-methoxyphenyl)-4-quinolinyl]methanone | [no description available] | low | 0 | 0 | quinolines | |
| N-(1,3-benzothiazol-2-yl)-2-(3-methoxyphenyl)-4-quinolinecarboxamide | [no description available] | low | 0 | 0 | quinolines | |
| 2-(4-ethylphenyl)-N-(4-methyl-1-piperazinyl)-4-quinolinecarboxamide | [no description available] | low | 0 | 0 | quinolines | |
| LSM-27108 | [no description available] | low | 0 | 0 | quinolines | |
| [2-(4-propylphenyl)-4-quinolinyl]-[4-(2-pyridinyl)-1-piperazinyl]methanone | [no description available] | low | 0 | 0 | quinolines | |
| 2-(4-propylphenyl)-N-[2-(4-sulfamoylphenyl)ethyl]-4-quinolinecarboxamide | [no description available] | low | 0 | 0 | quinolines | |
| 2-(3-bromophenyl)-6-methyl-N-(1,2,4-triazol-4-yl)-4-quinolinecarboxamide | [no description available] | low | 0 | 0 | quinolines | |
| N-(1,3-benzodioxol-5-yl)-6-methyl-2-(2-pyridinyl)-4-quinolinecarboxamide | [no description available] | low | 0 | 0 | quinolines | |
| [4-[(2-chlorophenyl)methyl]-1-piperazinyl]-(6,8-dimethyl-2-pyridin-4-yl-4-quinolinyl)methanone | [no description available] | low | 0 | 0 | quinolines | |
| 2-[[5-[(2-methyl-8-quinolinyl)oxymethyl]-4-prop-2-enyl-1,2,4-triazol-3-yl]thio]acetamide | [no description available] | low | 0 | 0 | quinolines | |
| 2-phenyl-N-(4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl)-4-quinolinecarboxamide | [no description available] | low | 0 | 0 | quinolines | |
| N-(4-fluorophenyl)-3-([1,2,4]triazolo[4,3-a]quinolin-1-ylthio)propanamide | [no description available] | low | 0 | 0 | quinolines | |
| 9-(3-bromo-4-hydroxyphenyl)-10-phenyl-3,4,5,6,7,9-hexahydro-2H-acridine-1,8-dione | [no description available] | low | 0 | 0 | quinolines | |
| [2-(4-methoxyphenyl)-6-methyl-4-quinolinyl]-(4-morpholinyl)methanone | [no description available] | low | 0 | 0 | quinolines | |
| 7-[4-(4-acetamidophenyl)sulfonyl-1-piperazinyl]-1-ethyl-6-fluoro-4-oxo-3-quinolinecarboxylic acid | [no description available] | low | 0 | 0 | quinolines | |
| N-[6-methoxy-1-(2-methylpropyl)-3-pyrazolo[3,4-b]quinolinyl]-3-methylbutanamide | [no description available] | low | 0 | 0 | quinolines | |
| 2-(8-methoxy-2-methyl-4-oxo-1-quinolinyl)-N-(2-methoxyphenyl)acetamide | [no description available] | low | 0 | 0 | quinolines | |
| N-[(6-methoxy-2-oxo-1H-quinolin-3-yl)methyl]-N-propan-2-yl-2-furancarboxamide | [no description available] | low | 0 | 0 | quinolines | |
| 1-[2-(3,4-dimethoxyphenyl)ethyl]-1-[(5,7-dimethyl-2-oxo-1H-quinolin-3-yl)methyl]-3-methylthiourea | [no description available] | low | 0 | 0 | quinolines | |
| 8,9-dimethyl-N-(3-methylphenyl)-3-[2-(4-morpholinyl)ethyl]-4H-[1,3]thiazino[6,5-b]quinolin-2-imine | [no description available] | low | 0 | 0 | quinolines | |
| 6-[[2-(4-morpholinyl)-2-oxoethyl]thio]-[1,3]dioxolo[4,5-g]quinoline-7-carbonitrile | [no description available] | low | 0 | 0 | quinolines | |
| N-[(6-methoxy-2-oxo-1H-quinolin-3-yl)methyl]-N-(2-phenylethyl)acetamide | [no description available] | low | 0 | 0 | quinolines | |
| N-[(4-fluorophenyl)methyl]-N-[(8-methyl-2-oxo-1H-quinolin-3-yl)methyl]-4-morpholinecarboxamide | [no description available] | low | 0 | 0 | quinolines | |
| 4-methyl-N-[(2-methyl-4-quinolinyl)methyl]-3-nitrobenzamide | [no description available] | low | 0 | 0 | quinolines | |
| 2-(3,5-dimethyl-4-nitro-1-pyrazolyl)-N-[(2-methyl-4-quinolinyl)methyl]acetamide | [no description available] | low | 0 | 0 | quinolines | |
| 2-phenyl-N-[4-(2-thiazolylsulfamoyl)phenyl]-4-quinolinecarboxamide | [no description available] | low | 0 | 0 | quinolines | |
| 1-ethyl-3-[[[2-(2-methylpropyl)-4-quinolinyl]-oxomethyl]amino]thiourea | [no description available] | low | 0 | 0 | quinolines | |
| 2-[6-bromo-4-(2-chlorophenyl)-2-oxo-1H-quinolin-3-yl]acetic acid | [no description available] | low | 0 | 0 | quinolines | |
| 3-cyclohexyl-10-methyl-2-thiophen-2-ylpyrimido[4,5-b]quinoline-4,5-dione | [no description available] | low | 0 | 0 | quinolines | |
| 2-(4-fluorophenyl)-3-(2-furanylmethyl)-10-methylpyrimido[4,5-b]quinoline-4,5-dione | [no description available] | low | 0 | 0 | quinolines | |
| N-(1-ethyl-6-methyl-3-pyrazolo[3,4-b]quinolinyl)-2-(4-methoxyphenyl)acetamide | [no description available] | low | 0 | 0 | quinolines | |
| N-[3-(2-methoxyphenyl)-1-methyl-4-oxo-2-quinolinyl]-2-methylpropanamide | [no description available] | low | 0 | 0 | quinolines | |
| N-(1,3-benzodioxol-5-ylmethyl)-8-quinolinesulfonamide | [no description available] | low | 0 | 0 | quinolines | |
| 1-(1,3-benzodioxol-5-ylmethylthio)-[1,2,4]triazolo[4,3-a]quinoline | [no description available] | low | 0 | 0 | quinolines | |
| N-(4,5-dihydrothiazol-2-yl)-2-thiophen-2-yl-4-quinolinecarboxamide | [no description available] | low | 0 | 0 | quinolines | |
| 2-(4-methoxyphenyl)-4-quinolinecarboxylic acid [2-oxo-2-(propan-2-ylamino)ethyl] ester | [no description available] | low | 0 | 0 | quinolines | |
| 2-(2-furanyl)-4-quinolinecarboxylic acid [2-[4-amino-1-methyl-3-(2-methylpropyl)-2,6-dioxo-5-pyrimidinyl]-2-oxoethyl] ester | [no description available] | low | 0 | 0 | quinolines | |
| 1-cyclopropyl-7-[4-(2,3-dihydro-1,4-benzodioxin-6-ylsulfonyl)-1-piperazinyl]-6-fluoro-4-oxo-3-quinolinecarboxylic acid | [no description available] | low | 0 | 0 | quinolines | |
| N-[5-(ethylthio)-1,3,4-thiadiazol-2-yl]-2-quinolinecarboxamide | [no description available] | low | 0 | 0 | quinolines | |
| N-(3-acetyl-2-methyl-5-benzofuranyl)-N-(8-quinolinylsulfonyl)acetamide | [no description available] | low | 0 | 0 | quinolines | |
| N-[3-(6-methyl-4-phenyl-2-quinolinyl)phenyl]methanesulfonamide | [no description available] | low | 0 | 0 | quinolines | |
| 2-[3-[(4-chlorophenyl)-oxomethyl]-6-methoxy-4-oxo-1-quinolinyl]-N-(4-fluorophenyl)acetamide | [no description available] | low | 0 | 0 | aromatic ketone; quinolines | |
| 5-[(4-fluorophenyl)methyl]-7-(4-methylphenyl)sulfonyl-[1,3]dioxolo[4,5-g]quinolin-8-one | [no description available] | low | 0 | 0 | quinolines | |
| [9-(4-ethoxyphenyl)sulfonyl-2,3-dihydro-[1,4]dioxino[2,3-g]quinolin-8-yl]-(4-methylphenyl)methanone | [no description available] | low | 0 | 0 | aromatic ketone; quinolines | |
| 2-[[5-(5-chloro-2-thiophenyl)-1,3,4-oxadiazol-2-yl]thio]-1-(3,4-dihydro-2H-quinolin-1-yl)ethanone | [no description available] | low | 0 | 0 | quinolines | |
| 2-quinolinecarboxylic acid (4-oxo-1,2,3-benzotriazin-3-yl)methyl ester | [no description available] | low | 0 | 0 | quinolines | |
| 3,4-dihydro-2H-quinolin-1-yl-(4-propoxyphenyl)methanone | [no description available] | low | 0 | 0 | quinolines | |
| N-(5-tert-butyl-3-isoxazolyl)-7-chloro-8-methyl-2-(2-pyridinyl)-4-quinolinecarboxamide | [no description available] | low | 0 | 0 | quinolines | |
| 6-bromo-N-(5-ethyl-1,3,4-thiadiazol-2-yl)-2-(2-pyridinyl)-4-quinolinecarboxamide | [no description available] | low | 0 | 0 | quinolines | |
| 8-quinolinecarboxylic acid phenyl ester | [no description available] | low | 0 | 0 | quinolines | |
| 1-[4-(5-fluoro-1,2-benzoxazol-3-yl)-1-piperidinyl]-2-[(4-methyl-2-quinolinyl)thio]ethanone | [no description available] | low | 0 | 0 | quinolines | |
| 8-[2-(4-chloro-3,5-dimethylphenoxy)ethoxy]quinoline | [no description available] | low | 0 | 0 | quinolines | |
| 8-[2-(4-chloro-2,5-dimethylphenoxy)ethoxy]quinoline | [no description available] | low | 0 | 0 | quinolines | |
| 8-[3-(3,4-dimethylphenoxy)propoxy]quinoline | [no description available] | low | 0 | 0 | quinolines | |
| 2-(4-methoxyphenyl)-N-[2-(4-morpholinyl)ethyl]-4-quinolinecarboxamide | [no description available] | low | 0 | 0 | quinolines | |
| 1-[(7-chloro-4-quinolinyl)amino]-3-(2,4-dichlorophenyl)thiourea | [no description available] | low | 0 | 0 | organochlorine compound; quinolines | |
| N-[4-[(4,6-dimethyl-2-pyrimidinyl)sulfamoyl]phenyl]-2-phenyl-4-quinolinecarboxamide | [no description available] | low | 0 | 0 | quinolines | |
| 3-[2-(4-fluorophenyl)-4-quinolinyl]-6,7,8,9-tetrahydro-5H-[1,2,4]triazolo[4,3-a]azepine | [no description available] | low | 0 | 0 | quinolines | |
| 2-(2-chlorophenyl)-N-[4-[(3,4-dimethyl-5-isoxazolyl)sulfamoyl]phenyl]-4-quinolinecarboxamide | [no description available] | low | 0 | 0 | quinolines | |
| N-(2-cyanophenyl)-2-[(5,7-dibromo-8-quinolinyl)oxy]acetamide | [no description available] | low | 0 | 0 | organohalogen compound; quinolines | |
| 5-bromo-2-furancarboxylic acid [2-(3,4-dihydro-2H-quinolin-1-yl)-2-oxoethyl] ester | [no description available] | low | 0 | 0 | quinolines | |
| 3-[2-(4-chlorophenyl)-4-quinolinyl]-6,7,8,9-tetrahydro-5H-[1,2,4]triazolo[4,3-a]azepine | [no description available] | low | 0 | 0 | quinolines | |
| 4-[4-(2,3,5,6-Tetramethylphenyl)sulfonylpiperazine-1-carbonyl]-1H-quinolin-2-one | [no description available] | low | 0 | 0 | quinolines | anticoronaviral agent |
| N-(5-methyl-1,3,4-thiadiazol-2-yl)-2-quinolinecarboxamide | [no description available] | low | 0 | 0 | quinolines | |
| 4,6,8-trimethyl-1H-quinoline-2-thione | [no description available] | low | 0 | 0 | quinolines | |
| 4-[4-(2,3-Dimethylphenyl)piperazine-1-carbonyl]-1H-quinolin-2-one | [no description available] | low | 0 | 0 | quinolines | anticoronaviral agent |
| 4-[4-[3-(Trifluoromethyl)phenyl]piperazine-1-carbonyl]-1H-quinolin-2-one | [no description available] | low | 0 | 0 | quinolines | anticoronaviral agent |
| 4-ethyl-3-[2-(4-methylphenyl)-4-quinolinyl]-1H-1,2,4-triazole-5-thione | [no description available] | low | 0 | 0 | quinolines | |
| 1-(2-benzofuranyl)-2-[(4-methyl-2-quinolinyl)thio]ethanone | [no description available] | low | 0 | 0 | quinolines | |
| N-[2-(2-Methoxyphenoxy)ethyl]-2-oxo-1H-quinoline-4-carboxamide | [no description available] | low | 0 | 0 | quinolines | anticoronaviral agent |
| 2-phenyl-N-(2-piperidin-1-ylethyl)quinolin-4-amine | [no description available] | low | 0 | 0 | quinolines | |
| 6-(4-methoxybenzyl)-3-methyl-5,6,7,8-tetrahydroquinoline | [no description available] | low | 0 | 0 | quinolines | |
| 8-methoxy-4-oxo-1H-quinoline-2-carboxylic acid methyl ester | [no description available] | low | 0 | 0 | quinolines | |
| N-(2-quinolinyl)cyclohexanecarboxamide | [no description available] | low | 0 | 0 | quinolines | |
| LSM-28160 | [no description available] | low | 0 | 0 | quinolines | |
| 2-(3,4-dimethoxyphenyl)quinoline | [no description available] | low | 0 | 0 | quinolines | |
| N-[2-[[2-(trifluoromethyl)-4-quinolinyl]thio]ethyl]methanesulfonamide | [no description available] | low | 0 | 0 | quinolines | |
| 5-nitro-8-(1-pyrrolidinyl)quinoline | [no description available] | low | 0 | 0 | nitro compound; quinolines | |
| 8-(2,3-dihydroxy-3-methylbutoxy)-4-methoxy-1-methyl-2-quinolinone | [no description available] | low | 0 | 0 | quinolines | |
| 4-Methoxy-1-methyl-8-((2,2,5,5-tetramethyl-1,3-dioxolan-4-yl)methoxy)quinolin-2(1H)-one | [no description available] | low | 0 | 0 | quinolines | |
| 2-[4-(2,2-dimethyl-4-oxo-1,3,5,6-tetrahydrobenzo[a]phenanthridin-5-yl)-2-methoxyphenoxy]acetic acid | [no description available] | low | 0 | 0 | quinolines | |
| 1-[8-chloro-4-(1-naphthalenyl)-3,3a,4,9b-tetrahydrocyclopenta[c]quinolin-5-yl]ethanone | [no description available] | low | 0 | 0 | quinolines | |
| 7,7-dimethyl-1-(4-methylphenyl)-2,5-dioxo-N-(2-oxo-3-thiolanyl)-6,8-dihydroquinoline-3-carboxamide | [no description available] | low | 0 | 0 | quinolines | |
| N-(5-tert-butyl-1,3,4-thiadiazol-2-yl)-2-phenyl-4-quinolinecarboxamide | [no description available] | low | 0 | 0 | quinolines | |
| 1-(8-quinolinylsulfonyl)-3-piperidinecarboxylic acid ethyl ester | [no description available] | low | 0 | 0 | quinolines | |
| N-ethyl-N-[2-[(5-nitro-8-quinolinyl)amino]ethyl]benzenesulfonamide | [no description available] | low | 0 | 0 | nitro compound; quinolines | |
| 2,5-dimethoxy-n-(quinolin-3-yl)benzenesulfonamide | [no description available] | low | 0 | 0 | quinolines | |
| N-(4-carbamoylphenyl)-2-(4-methoxyphenyl)-4-quinolinecarboxamide | [no description available] | low | 0 | 0 | quinolines | |
| 4-ethoxy-N-(3-quinolinyl)benzenesulfonamide | [no description available] | low | 0 | 0 | quinolines | |
| [2-(3-chlorophenyl)-4-quinolinyl]-[4-(2-pyridinyl)-1-piperazinyl]methanone | [no description available] | low | 0 | 0 | quinolines | |
| [4-(benzenesulfonyl)-1-piperazinyl]-[6-bromo-2-(2-pyridinyl)-4-quinolinyl]methanone | [no description available] | low | 0 | 0 | quinolines | |
| 5-chloro-7-[3-pyridinyl-(2-pyridinylamino)methyl]-8-quinolinol | [no description available] | low | 0 | 0 | organochlorine compound; quinolines | |
| 6-[[4-(3,4-dihydro-2H-quinolin-1-ylsulfonyl)anilino]-oxomethyl]-1-cyclohex-3-enecarboxylic acid | [no description available] | low | 0 | 0 | quinolines | |
| cb 7969312 | [no description available] | low | 0 | 0 | organochlorine compound; quinolines | |
| LSM-18518 | [no description available] | low | 0 | 0 | quinolines | |
| 3-methyl-N-[[(2-methyl-5-quinolinyl)amino]-sulfanylidenemethyl]benzamide | [no description available] | low | 0 | 0 | quinolines | |
| 2-quinolinecarboxylic acid (2-oxo-3-oxolanyl) ester | [no description available] | low | 0 | 0 | quinolines | |
| 3-(3,4-dihydro-2H-quinolin-1-ylmethyl)-6,7,8,9-tetrahydro-5H-[1,2,4]triazolo[4,3-a]azepine | [no description available] | low | 0 | 0 | quinolines | |
| [4-(2-pyridinyl)-1-piperazinyl]-[2-(3,4,5-trimethoxyphenyl)-4-quinolinyl]methanone | [no description available] | low | 0 | 0 | quinolines | |
| 2-(2-furanyl)-N-(2-oxolanylmethyl)-4-quinolinecarboxamide | [no description available] | low | 0 | 0 | quinolines | |
| 2-(3,4-dimethoxyphenyl)-4-quinolinecarboxylic acid (2-oxo-3-oxolanyl) ester | [no description available] | low | 0 | 0 | quinolines | |
| 1-[1-chloro-2-[(2-nitrophenyl)thio]-4-phenyl-2,3,3a,4,5,9b-hexahydro-1H-cyclopenta[c]quinolin-8-yl]ethanone | [no description available] | low | 0 | 0 | quinolines | |
| 4-(6-bromo-1,3-benzodioxol-5-yl)-3a,4,5,9b-tetrahydro-3H-cyclopenta[c]quinoline | [no description available] | low | 0 | 0 | quinolines | |
| 4-(6-bromo-1,3-benzodioxol-5-yl)-7,9-dimethyl-3a,4,5,9b-tetrahydro-3H-cyclopenta[c]quinoline | [no description available] | low | 0 | 0 | quinolines | |
| 1-[4-(6-bromo-1,3-benzodioxol-5-yl)-3a,4,5,9b-tetrahydro-3H-cyclopenta[c]quinolin-8-yl]ethanone | [no description available] | low | 0 | 0 | quinolines | |
| N'-[2-[(6-methoxy-2-methyl-4-quinolinyl)thio]-1-oxoethyl]-2-(1-naphthalenyloxy)acetohydrazide | [no description available] | low | 0 | 0 | quinolines | |
| 9-(2-ethoxy-3-methoxyphenyl)-3,6,8,9-tetrahydro-2H-[1,4]dioxino[2,3-g]quinolin-7-one | [no description available] | low | 0 | 0 | quinolines | |
| 2-(1,5-dimethyl-4-pyrazolyl)-4-quinolinecarboxylic acid | [no description available] | low | 0 | 0 | quinolines | |
| 1-[(5,8-dimethyl-2-oxo-1H-quinolin-3-yl)methyl]-1-(2-furanylmethyl)-3-(2-oxolanylmethyl)thiourea | [no description available] | low | 0 | 0 | quinolines | |
| 1-[2-(dimethylamino)ethyl]-1-[(6-oxo-5H-[1,3]dioxolo[4,5-g]quinolin-7-yl)methyl]-3-(2-oxolanylmethyl)thiourea | [no description available] | low | 0 | 0 | quinolines | |
| 3-ethyl-1-(2-furanylmethyl)-1-[(7-oxo-3,6-dihydro-2H-[1,4]dioxino[2,3-g]quinolin-8-yl)methyl]thiourea | [no description available] | low | 0 | 0 | quinolines | |
| 1-[2-(diethylamino)ethyl]-1-[(7-oxo-3,6-dihydro-2H-[1,4]dioxino[2,3-g]quinolin-8-yl)methyl]-3-(2-oxolanylmethyl)thiourea | [no description available] | low | 0 | 0 | quinolines | |
| 1-[(6,7-dimethoxy-2-oxo-1H-quinolin-3-yl)methyl]-1-[2-(3-methylphenyl)ethyl]-3-[3-(4-morpholinyl)propyl]thiourea | [no description available] | low | 0 | 0 | quinolines | |
| N-[(6-methoxy-2-oxo-1H-quinolin-3-yl)methyl]-5-methyl-N-(thiophen-2-ylmethyl)-2,1,3-benzothiadiazole-4-sulfonamide | [no description available] | low | 0 | 0 | quinolines | |
| 3-butan-2-yl-1-[(6,7-dimethoxy-2-oxo-1H-quinolin-3-yl)methyl]-1-(2-phenylethyl)thiourea | [no description available] | low | 0 | 0 | quinolines | |
| 2-[(3,6-dimethyl-2-quinolinyl)thio]-1-(2-methyl-2,3-dihydroindol-1-yl)ethanone | [no description available] | low | 0 | 0 | quinolines | |
| 3-(2,4-dimethoxyphenyl)-1-[(1-ethyl-2-pyrrolidinyl)methyl]-1-[(7-methyl-2-oxo-1H-quinolin-3-yl)methyl]thiourea | [no description available] | low | 0 | 0 | quinolines | |
| 4-ethoxy-N-[(6-methoxy-2-oxo-1H-quinolin-3-yl)methyl]-N-[(4-methoxyphenyl)methyl]benzamide | [no description available] | low | 0 | 0 | quinolines | |
| 3-(4-fluorophenyl)-1-[(6-oxo-5H-[1,3]dioxolo[4,5-g]quinolin-7-yl)methyl]-1-(thiophen-2-ylmethyl)urea | [no description available] | low | 0 | 0 | quinolines | |
| 2-[(3-cyano-8-methyl-2-quinolinyl)thio]-N-(2-oxolanylmethyl)acetamide | [no description available] | low | 0 | 0 | quinolines | |
| N-(2,4-dioxo-1H-pyrimidin-5-yl)-2-[(3-ethyl-5,8-dimethyl-2-quinolinyl)thio]acetamide | [no description available] | low | 0 | 0 | quinolines | |
| N-[2-(cyclohexylamino)-2-oxo-1-(6-quinolinyl)ethyl]-N-[(4-fluorophenyl)methyl]-2,3-dihydro-1,4-benzodioxin-6-carboxamide | [no description available] | low | 0 | 0 | quinolines | |
| 3,4-dihydro-2H-quinolin-1-yl-[4-(phenylmethyl)-5-thieno[3,2-b]pyrrolyl]methanone | [no description available] | low | 0 | 0 | quinolines | |
| 4-[2-(3,4-dihydro-2H-quinolin-1-yl)-2-oxoethyl]-2-methyl-5-furo[3,2-b]pyrrolecarboxylic acid methyl ester | [no description available] | low | 0 | 0 | quinolines | |
| 6-[(2-methoxyphenyl)methylsulfamoyl]-4-oxo-1H-quinoline-3-carboxylic acid | [no description available] | low | 0 | 0 | quinolines | |
| 2-[(3,5-dimethyl-4-isoxazolyl)methylthio]-4-ethyl-7,7-dimethyl-5-oxo-6,8-dihydroquinoline-3-carbonitrile | [no description available] | low | 0 | 0 | quinolines | |
| 4-[(1-methyl-2-oxo-4-quinolinyl)oxy]-N-(4-methyl-2-pyridinyl)butanamide | [no description available] | low | 0 | 0 | quinolines | |
| N-[2-(6,7-dimethyl-2-oxo-1H-quinolin-3-yl)ethyl]-1-propanesulfonamide | [no description available] | low | 0 | 0 | quinolines | |
| N-[2-(6,7-dimethyl-2-oxo-1H-quinolin-3-yl)ethyl]ethanesulfonamide | [no description available] | low | 0 | 0 | quinolines | |
| N-(2-methyl-4-oxo-1-propyl-6-quinolinyl)-2-pyrazinecarboxamide | [no description available] | low | 0 | 0 | quinolines | |
| 3,4-dihydro-2H-quinolin-1-yl-(7-methoxy-4,5-dihydrobenzo[g][1,2]benzoxazol-3-yl)methanone | [no description available] | low | 0 | 0 | quinolines | |
| 4,5-dihydrobenzo[g][1,2]benzoxazol-3-yl(3,4-dihydro-2H-quinolin-1-yl)methanone | [no description available] | low | 0 | 0 | quinolines | |
| 9-(4-methoxyphenyl)-3,3,6,6-tetramethyl-10-[2-(4-morpholinyl)ethyl]-4,5,7,9-tetrahydro-2H-acridine-1,8-dione | [no description available] | low | 0 | 0 | quinolines | |
| 2-(2,4-dimethoxyanilino)-N-[3-(4-methyl-1-piperazinyl)propyl]-4-quinolinecarboxamide | [no description available] | low | 0 | 0 | quinolines | |
| 1-[oxo-[4-oxo-6-[(4-propan-2-ylphenyl)sulfamoyl]-1H-quinolin-3-yl]methyl]-4-piperidinecarboxamide | [no description available] | low | 0 | 0 | aromatic amide; quinolines | |
| [4-[6-(4-morpholinyl)-3-pyridazinyl]-1-piperazinyl]-(2-pyridin-4-yl-4-quinolinyl)methanone | [no description available] | low | 0 | 0 | quinolines | |
| 5-bromo-N-[2-(6,7-dimethyl-2-oxo-1H-quinolin-3-yl)ethyl]-2-furancarboxamide | [no description available] | low | 0 | 0 | quinolines | |
| 6-[(2-ethylphenyl)sulfamoyl]-N-(2-furanylmethyl)-4-oxo-1H-quinoline-3-carboxamide | [no description available] | low | 0 | 0 | aromatic amide; quinolines | |
| N-ethyl-3-[4-morpholinyl(oxo)methyl]-4-oxo-N-phenyl-1H-quinoline-6-sulfonamide | [no description available] | low | 0 | 0 | aromatic amide; quinolines | |
| 2-ethyl-N-[2-(7-methoxy-2-oxo-1H-quinolin-3-yl)ethyl]butanamide | [no description available] | low | 0 | 0 | quinolines | |
| 3,4-dihydro-2H-quinolin-1-yl-[5-(4-methoxyphenyl)-3-isoxazolyl]methanone | [no description available] | low | 0 | 0 | quinolines | |
| 6-[(2-ethylphenyl)sulfamoyl]-4-oxo-N-(2-oxolanylmethyl)-1H-quinoline-3-carboxamide | [no description available] | low | 0 | 0 | aromatic amide; quinolines | |
| N-(1,3-benzodioxol-5-yl)-2-[(1-ethyl-2-oxo-4-quinolinyl)thio]acetamide | [no description available] | low | 0 | 0 | quinolines | |
| 6-(1-azepanylsulfonyl)-1-ethyl-N-(2-furanylmethyl)-4-oxo-3-quinolinecarboxamide | [no description available] | low | 0 | 0 | aromatic amide; quinolines | |
| N-[2-(7-methoxy-2-oxo-1H-quinolin-3-yl)ethyl]cyclopropanecarboxamide | [no description available] | low | 0 | 0 | quinolines | |
| N-[3-(3,5-dimethyl-1-piperidinyl)propyl]-2-[(1-methyl-2-oxo-4-quinolinyl)oxy]acetamide | [no description available] | low | 0 | 0 | quinolines | |
| 1-acetyl-N-propyl-3,4-dihydro-2H-quinoline-6-sulfonamide | [no description available] | low | 0 | 0 | quinolines | |
| 2-(2,5-dimethoxyanilino)-N-[3-(4-morpholinyl)propyl]-4-quinolinecarboxamide | [no description available] | low | 0 | 0 | quinolines | |
| 3-acetyl-6-methyl-1H-quinolin-4-one | [no description available] | low | 0 | 0 | quinolines | |
| 2-amino-4-[4-(methylthio)phenyl]-5-oxo-1-phenyl-4,6,7,8-tetrahydroquinoline-3-carbonitrile | [no description available] | low | 0 | 0 | quinolines | |
| N-[1-(2,3-dihydro-1,4-benzodioxin-6-yl)ethyl]-1-methyl-4-oxo-6-(1-pyrrolidinylsulfonyl)-3-quinolinecarboxamide | [no description available] | low | 0 | 0 | aromatic amide; quinolines | |
| N-butan-2-yl-6-[(4-ethoxyphenyl)sulfamoyl]-4-oxo-1H-quinoline-3-carboxamide | [no description available] | low | 0 | 0 | aromatic amide; quinolines | |
| 1-methyl-6-[(4-methyl-1-piperidinyl)sulfonyl]-3-[oxo(1-piperidinyl)methyl]-4-quinolinone | [no description available] | low | 0 | 0 | aromatic amide; quinolines | |
| 1-methyl-N-(2-methylcyclohexyl)-4-oxo-6-(1-pyrrolidinylsulfonyl)-3-quinolinecarboxamide | [no description available] | low | 0 | 0 | aromatic amide; quinolines | |
| 8-(2-propoxyphenyl)-7,8-dihydro-5H-[1,3]dioxolo[4,5-g]quinolin-6-one | [no description available] | low | 0 | 0 | quinolines | |
| 2,6-dimethyl-4-(4-phenyl-2-quinolinyl)morpholine | [no description available] | low | 0 | 0 | quinolines | |
| quinoxyfen | [no description available] | low | 0 | 0 | aromatic ether; monofluorobenzenes; organochlorine compound; quinolines | antifungal agrochemical |
| N-[4-(methoxymethyl)-6-methyl-2-oxo-1H-quinolin-7-yl]cyclopropanecarboxamide | [no description available] | low | 0 | 0 | quinolines | |
| N-[2-(4-morpholinyl)ethyl]-2-(4-propan-2-yloxyphenyl)-4-quinolinecarboxamide | [no description available] | low | 0 | 0 | quinolines | |
| 5-chloro-7-[1-piperidinyl(2-pyridinyl)methyl]-8-quinolinol | [no description available] | low | 0 | 0 | organochlorine compound; quinolines | |
| 4-(3,4-dihydro-2H-quinolin-1-ylsulfonyl)-N-(5-ethyl-1,3,4-oxadiazol-2-yl)benzamide | [no description available] | low | 0 | 0 | quinolines | |
| 5-chloro-7-[(4-ethyl-1-piperazinyl)-(3-pyridinyl)methyl]-8-quinolinol | [no description available] | low | 0 | 0 | organochlorine compound; quinolines | |
| N-[2-(6,7-dimethyl-2-oxo-1H-quinolin-3-yl)ethyl]-2-thiophenecarboxamide | [no description available] | low | 0 | 0 | quinolines | |
| 6-bromo-2-(4-methylphenyl)-N-[(1-methyl-4-pyrazolyl)methyl]-4-quinolinecarboxamide | [no description available] | low | 0 | 0 | quinolines | |
| 3-acetyl-6-bromo-2-methyl-4-quinolinecarboxylic acid | [no description available] | low | 0 | 0 | quinolines | |
| 2-thiophen-2-yl-4-quinolinecarboxylic acid (2-oxo-3-oxolanyl) ester | [no description available] | low | 0 | 0 | quinolines | |
| 6,8-dibromo-2-thiophen-2-ylquinoline | [no description available] | low | 0 | 0 | organohalogen compound; quinolines | |
| N-(4-methylphenyl)-2-oxo-3,4-dihydro-1H-quinoline-6-sulfonamide | [no description available] | low | 0 | 0 | quinolines | |
| 2-(4-methoxyphenyl)-N-[2-(4-morpholinyl)-5-(4-morpholinylsulfonyl)phenyl]-4-quinolinecarboxamide | [no description available] | low | 0 | 0 | quinolines | |
| N-(3-methylbutyl)-6-(4-morpholinylsulfonyl)-2-pyridin-4-yl-4-quinolinecarboxamide | [no description available] | low | 0 | 0 | quinolines | |
| 2-(4-ethoxyphenyl)-N-[3-(1-imidazolyl)propyl]-4-quinolinecarboxamide | [no description available] | low | 0 | 0 | quinolines | |
| 7-ethoxy-3-[5-(2-furanyl)-2-methylsulfonyl-3,4-dihydropyrazol-3-yl]-1H-quinolin-2-one | [no description available] | low | 0 | 0 | quinolines | |
| 2-amino-4-(5-bromo-2-thiophenyl)-5,6,7,8-tetrahydroquinoline-3-carbonitrile | [no description available] | low | 0 | 0 | quinolines | |
| N-[(5-quinolinylamino)-sulfanylidenemethyl]benzamide | [no description available] | low | 0 | 0 | quinolines | |
| 7-[(3-hydroxy-3,4-dihydro-2H-benzo[h]quinolin-1-yl)methyl]-5-thiazolo[3,2-a]pyrimidinone | [no description available] | low | 0 | 0 | quinolines | |
| N-(3,5-dichloro-2-pyridinyl)-2-[(4-methyl-2-quinolinyl)thio]propanamide | [no description available] | low | 0 | 0 | quinolines | |
| 2-amino-1-(dimethylamino)-4-(1-naphthalenyl)-5-oxo-7-phenyl-4,6,7,8-tetrahydroquinoline-3-carbonitrile | [no description available] | low | 0 | 0 | naphthalenes; quinolines | |
| 2-(2-chlorophenyl)-N-[3-(3,4,5,6-tetrahydro-2H-azepin-7-ylsulfamoyl)phenyl]-4-quinolinecarboxamide | [no description available] | low | 0 | 0 | quinolines | |
| 2-phenyl-4-quinolinecarboxylic acid [2-[2-chloro-5-(dimethylsulfamoyl)anilino]-2-oxoethyl] ester | [no description available] | low | 0 | 0 | quinolines | |
| 2-amino-4-(3,4-dimethoxyphenyl)-7,7-dimethyl-5-oxo-1-(3-pyridinyl)-6,8-dihydro-4H-quinoline-3-carbonitrile | [no description available] | low | 0 | 0 | quinolines | |
| 2-(1-naphthalenyl)-4-quinolinecarboxylic acid [1-[(1,5-dimethyl-3-oxo-2-phenyl-4-pyrazolyl)amino]-1-oxopropan-2-yl] ester | [no description available] | low | 0 | 0 | naphthalenes; quinolines | |
| 2-(5-bromo-2-thiophenyl)-N-(4-methyl-1-piperazinyl)-4-quinolinecarboxamide | [no description available] | low | 0 | 0 | quinolines | |
| [3,5-bis(difluoromethyl)-5-hydroxy-4H-pyrazol-1-yl]-[2-(4-propan-2-ylphenyl)-4-quinolinyl]methanone | [no description available] | low | 0 | 0 | quinolines | |
| [2-(3,4-dimethylphenyl)-4-quinolinyl]-(1-piperidinyl)methanone | [no description available] | low | 0 | 0 | quinolines | |
| sb 408124 | [no description available] | low | 0 | 0 | organohalogen compound; quinolines | |
| 2-(4-fluorophenyl)-4-quinolinecarboxylic acid [2-oxo-2-(2-oxolanylmethylamino)ethyl] ester | [no description available] | low | 0 | 0 | quinolines | |
| 5-[3-(2-chloro-6-methoxy-3-quinolinyl)-5-(2-furanyl)-3,4-dihydropyrazol-2-yl]-5-oxopentanoic acid | [no description available] | low | 0 | 0 | organochlorine compound; quinolines | |
| [3-(2-chloro-6-ethoxy-3-quinolinyl)-5-phenyl-3,4-dihydropyrazol-2-yl]-thiophen-2-ylmethanone | [no description available] | low | 0 | 0 | organochlorine compound; quinolines | |
| flosequinan | [no description available] | low | 0 | 0 | quinolines | |
| N-(3,4-dimethylphenyl)-2-oxo-3,4-dihydro-1H-quinoline-6-sulfonamide | [no description available] | low | 0 | 0 | quinolines | |
| 1-[(4-fluorophenyl)-oxomethyl]-3-[(5-methyl-[1,2,4]triazolo[4,3-a]quinolin-1-yl)thio]-2-azepanone | [no description available] | low | 0 | 0 | quinolines | |
| 7,7-dimethyl-1-(4-methylphenyl)-N-[3-(4-morpholinyl)propyl]-2,5-dioxo-6,8-dihydroquinoline-3-carboxamide | [no description available] | low | 0 | 0 | quinolines | |
| 2-(4-bromophenyl)-4-quinolinecarboxylic acid (2-oxo-3-oxolanyl) ester | [no description available] | low | 0 | 0 | quinolines | |
| N-(5-methyl-3-isoxazolyl)-2-(4-propan-2-yloxyphenyl)-4-quinolinecarboxamide | [no description available] | low | 0 | 0 | quinolines | |
| 2-methyl-1-cyclopropanecarboxylic acid [5-[2-(3,4-dimethoxyphenyl)-4-quinolinyl]-1,3,4-oxadiazol-2-yl]methyl ester | [no description available] | low | 0 | 0 | quinolines | |
| 1-(4-bromophenyl)-1'-methyl-6'-nitro-2'-phenylspiro[1,3-diazinane-5,3'-2,4-dihydroquinoline]-2,4,6-trione | [no description available] | low | 0 | 0 | quinolines | |
| 1-phenylspiro[1,3-diazinane-5,5'-2,4,4a,6-tetrahydro-1H-[1,4]oxazino[4,3-a]quinoline]-2,4,6-trione | [no description available] | low | 0 | 0 | quinolines | |
| LSM-4833 | [no description available] | low | 0 | 0 | quinolines | |
| 1-[[3-(4-chlorophenyl)-4,5-dihydroisoxazol-5-yl]methyl]-4-methyl-2-quinolinone | [no description available] | low | 0 | 0 | quinolines | |
| 4-[[2-(4-ethyl-1-piperazinyl)-2-oxoethyl]thio]-1-methyl-2-quinolinone | [no description available] | low | 0 | 0 | quinolines | |
| 2-[2-(7-methoxy-2-oxo-1H-quinolin-3-yl)ethyl]isoindole-1,3-dione | [no description available] | low | 0 | 0 | quinolines | |
| montelukast | [no description available] | low | 0 | 0 | aliphatic sulfide; monocarboxylic acid; quinolines | anti-arrhythmia drug; anti-asthmatic drug; leukotriene antagonist |
| l 660,711 | [no description available] | low | 0 | 0 | quinolines | |
| pitavastatin | [no description available] | low | 0 | 0 | cyclopropanes; dihydroxy monocarboxylic acid; monofluorobenzenes; quinolines; statin (synthetic) | antioxidant |
| 1-[(2-oxo-3,4-dihydro-1H-quinolin-6-yl)sulfonyl]-N-(1,2,3,4-tetrahydronaphthalen-1-yl)-4-piperidinecarboxamide | [no description available] | low | 0 | 0 | quinolines | |
| 1-(3-amino-7-methoxy-1-pyrazolo[3,4-b]quinolinyl)-2-(2-methoxyphenyl)ethanone | [no description available] | low | 0 | 0 | quinolines | |
| N-(2-ethoxyphenyl)-1-(8-quinolinylsulfonyl)-3-piperidinecarboxamide | [no description available] | low | 0 | 0 | quinolines | |
| N-[2-(1-pyrrolidinyl)ethyl]-8-quinolinesulfonamide | [no description available] | low | 0 | 0 | quinolines | |
| N-[[4-(dimethylamino)phenyl]methyl]-2-[methyl(8-quinolinylsulfonyl)amino]acetamide | [no description available] | low | 0 | 0 | quinolines | |
| N-[(2-methoxyphenyl)methyl]-1-(8-quinolinylsulfonyl)-4-piperidinecarboxamide | [no description available] | low | 0 | 0 | quinolines | |
| evocarpine | [no description available] | low | 0 | 0 | quinolines | |
| 4-[(3aR,4S,9bS)-8-[(4-methoxyphenyl)sulfamoyl]-3a,4,5,9b-tetrahydro-3H-cyclopenta[c]quinolin-4-yl]benzoic acid | [no description available] | low | 0 | 0 | quinolines | |
| Bucharaine | [no description available] | low | 0 | 0 | quinolines | |
| bedaquiline | [no description available] | low | 0 | 0 | aromatic ether; naphthalenes; organobromine compound; quinolines; tertiary alcohol; tertiary amino compound | antitubercular agent; ATP synthase inhibitor |
| 1,1'-diethyl-2,2'-cyanine | [no description available] | low | 0 | 0 | 1,1'-diethyl-2,2'-cyanine; quinolines | |
| penicillin v | [no description available] | low | 0 | 0 | 1,1'-diethyl-2,2'-cyanine; quinolines | |
| salubrinal | [no description available] | low | 0 | 0 | aminal; organochlorine compound; quinolines; secondary carboxamide; thioureas | |
| 2-(1-ethyl-4-pyrazolyl)-4-quinolinecarboxylic acid | [no description available] | low | 0 | 0 | quinolines | |
| 4-[2-(3,4-dimethoxyphenyl)ethylamino]-2-oxo-1H-quinoline-3-carboxaldehyde | [no description available] | low | 0 | 0 | quinolines | |
| sb 222200 | [no description available] | low | 0 | 0 | quinolines | |
| l 689560 | [no description available] | low | 0 | 0 | quinolines | |
| sb 218795 | [no description available] | low | 0 | 0 | quinolines | |
| 1-(3-amino-7-methoxy-1-pyrazolo[3,4-b]quinolinyl)-2-(4-chlorophenyl)ethanone | [no description available] | low | 0 | 0 | quinolines | |
| N-butyl-N-phenyl-8-quinolinesulfonamide | [no description available] | low | 0 | 0 | quinolines | |
| ik 682 | [no description available] | low | 0 | 0 | hydroxamic acid; pyrrolidin-2-ones; quinolines | |
| N-(3-methylphenyl)-2-oxo-3,4-dihydro-1H-quinoline-6-sulfonamide | [no description available] | low | 0 | 0 | quinolines | |
| 3-butyl-10-phenylpyrimido[4,5-b]quinoline-2,4-dione | [no description available] | low | 0 | 0 | quinolines | |
| N-(4-fluorophenyl)-2-oxo-3,4-dihydro-1H-quinoline-6-sulfonamide | [no description available] | low | 0 | 0 | quinolines | |
| N-[2-(3-methoxyphenyl)-4-[(4-methoxyphenyl)methoxy]-6-quinolinyl]-3-pyridinecarboxamide | [no description available] | low | 0 | 0 | quinolines | |
| pq 401 | [no description available] | low | 0 | 0 | quinolines | |
| 3-(4-ethoxyphenyl)-1-[3-(4-morpholinyl)propyl]-1-[(1-propyl-3,4-dihydro-2H-quinolin-6-yl)methyl]urea | [no description available] | low | 0 | 0 | quinolines | |
| lenvatinib | [no description available] | low | 0 | 0 | aromatic amide; aromatic ether; cyclopropanes; monocarboxylic acid amide; monochlorobenzenes; phenylureas; quinolines | antineoplastic agent; EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor; fibroblast growth factor receptor antagonist; orphan drug; vascular endothelial growth factor receptor antagonist |
| ozenoxacin | [no description available] | low | 0 | 0 | quinolines | |
| jte 907 | [no description available] | low | 0 | 0 | aromatic amide; quinolines | |
| hki 272 | [no description available] | low | 0 | 0 | nitrile; quinolines | antineoplastic agent; tyrosine kinase inhibitor |
| tan 67 | [no description available] | low | 0 | 0 | quinolines | |
| ly-2157299 | [no description available] | low | 0 | 0 | aromatic amide; methylpyridines; monocarboxylic acid amide; pyrrolopyrazole; quinolines | antineoplastic agent; TGFbeta receptor antagonist |
| 5-iodo-6-nitro-2-piperazinylquinoline | [no description available] | low | 0 | 0 | nitro compound; quinolines | |
| besifloxacin | [no description available] | low | 0 | 0 | quinolines | |
| ofloxacin n-oxide | [no description available] | low | 0 | 0 | quinolines | |
| crenolanib | [no description available] | low | 0 | 0 | aminopiperidine; aromatic ether; benzimidazoles; oxetanes; quinolines; tertiary amino compound | angiogenesis inhibitor; antineoplastic agent; apoptosis inducer; EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor |
| ki11502 | [no description available] | low | 0 | 0 | aromatic ether; benzamides; quinolines; thioureas | antineoplastic agent; apoptosis inducer; EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor |
| pf 573228 | [no description available] | low | 0 | 0 | quinolines | |
| osi 906 | [no description available] | low | 0 | 0 | cyclobutanes; quinolines | |
| dactolisib | [no description available] | low | 0 | 0 | imidazoquinoline; nitrile; quinolines; ring assembly; ureas | antineoplastic agent; EC 2.7.1.137 (phosphatidylinositol 3-kinase) inhibitor; mTOR inhibitor |
| nemonoxacin | [no description available] | low | 0 | 0 | quinolines | |
| [9-(benzenesulfonyl)-2,3-dihydro-[1,4]dioxino[2,3-g]quinolin-8-yl]-(4-methylphenyl)methanone | [no description available] | low | 0 | 0 | aromatic ketone; quinolines | |
| 1-(phenylmethyl)-4-quinolinone | [no description available] | low | 0 | 0 | quinolines | |
| CDN1163 | [no description available] | low | 0 | 0 | aromatic ether; quinolines; secondary carboxamide | SERCA activator |
| 3,5-dimethoxy-N-[1-[oxo(thiophen-2-yl)methyl]-3,4-dihydro-2H-quinolin-6-yl]benzamide | [no description available] | low | 0 | 0 | quinolines | |
| picogreen | [no description available] | low | 0 | 0 | benzothiazoles; cyanine dye; quinolines; tertiary amine | fluorescent dye |
| 1-[(1-ethyl-3,4-dihydro-2H-quinolin-6-yl)methyl]-3-(3-methylphenyl)-1-[2-(4-morpholinyl)ethyl]thiourea | [no description available] | low | 0 | 0 | quinolines | |
| 1-[(1-ethyl-3,4-dihydro-2H-quinolin-6-yl)methyl]-3-(4-methylphenyl)-1-[2-(4-morpholinyl)ethyl]thiourea | [no description available] | low | 0 | 0 | quinolines | |
| 1-[(1-ethyl-3,4-dihydro-2H-quinolin-6-yl)methyl]-3-(3-methoxyphenyl)-1-[2-(4-morpholinyl)ethyl]thiourea | [no description available] | low | 0 | 0 | quinolines | |
| 2-[4-[(6-ethoxy-2-quinolinyl)methyl]-1-(3-thiophenylmethyl)-2-piperazinyl]ethanol | [no description available] | low | 0 | 0 | quinolines | |
| nk 5 | [no description available] | low | 0 | 0 | organic iodide salt; quinolines | fluorochrome |
| peniprequinolone | [no description available] | low | 0 | 0 | quinolines | |
| pf 04217903 | [no description available] | low | 0 | 0 | quinolines | |
| sgx 523 | [no description available] | low | 0 | 0 | aryl sulfide; biaryl; pyrazoles; quinolines; triazolopyridazine | c-Met tyrosine kinase inhibitor; nephrotoxic agent |
| AMG-208 | [no description available] | low | 0 | 0 | aromatic ether; quinolines; triazolopyridazine | antineoplastic agent; c-Met tyrosine kinase inhibitor |
| lucitanib | [no description available] | low | 0 | 0 | aromatic ether; cyclopropanes; naphthalenecarboxamide; primary amino compound; quinolines | antineoplastic agent; fibroblast growth factor receptor antagonist; vascular endothelial growth factor receptor antagonist |
| dcc-2036 | [no description available] | low | 0 | 0 | organofluorine compound; phenylureas; pyrazoles; pyridinecarboxamide; quinolines | tyrosine kinase inhibitor |
| cabozantinib | [no description available] | low | 0 | 0 | aromatic ether; dicarboxylic acid diamide; organofluorine compound; quinolines | antineoplastic agent; tyrosine kinase inhibitor |
| pf 750 | [no description available] | low | 0 | 0 | quinolines | |
| gsk 2126458 | [no description available] | low | 0 | 0 | aromatic ether; difluorobenzene; pyridazines; pyridines; quinolines; sulfonamide | anticoronaviral agent; antineoplastic agent; autophagy inducer; EC 2.7.1.137 (phosphatidylinositol 3-kinase) inhibitor; mTOR inhibitor; radiosensitizing agent |
| N-[(8-methoxy-5-nitro-7-quinolinyl)-thiophen-2-ylmethyl]propanamide | [no description available] | low | 0 | 0 | nitro compound; quinolines | |
| iwr-1 endo | [no description available] | low | 0 | 0 | benzamides; bridged compound; dicarboximide; quinolines | axin stabilizer; Wnt signalling inhibitor |
| jnj38877605 | [no description available] | low | 0 | 0 | quinolines | |
| torin 1 | [no description available] | low | 0 | 0 | N-acylpiperazine; N-arylpiperazine; organofluorine compound; pyridoquinoline; quinolines | antineoplastic agent; mTOR inhibitor |
| DMH1 | [no description available] | low | 0 | 0 | aromatic ether; pyrazolopyrimidine; quinolines | antineoplastic agent; bone morphogenetic protein receptor antagonist; protein kinase inhibitor |
| 1-butyl-4-hydroxy-N-(3-methyl-2-pyridinyl)-2-oxo-3-quinolinecarboxamide | [no description available] | low | 0 | 0 | aromatic amide; quinolines | |
| 4-hydroxy-2-oxo-1-propyl-N-(pyridin-4-ylmethyl)-3-quinolinecarboxamide | [no description available] | low | 0 | 0 | aromatic amide; quinolines | |
| 4-hydroxy-1-methyl-3-(phenylthio)-1,2-dihydroquinolin-2-one | [no description available] | low | 0 | 0 | quinolines | |
| LSM-23865 | [no description available] | low | 0 | 0 | quinolines | |
| N-[(4-chlorophenyl)methyl]-4-hydroxy-2-oxo-1-prop-2-enyl-3-quinolinecarboxamide | [no description available] | low | 0 | 0 | aromatic amide; quinolines | |
| 4-hydroxy-1-methyl-2-oxo-N-(4-oxo-2-propyl-3-quinazolinyl)-3-quinolinecarboxamide | [no description available] | low | 0 | 0 | aromatic amide; quinolines | |
| 1-butyl-N-[(4-chlorophenyl)methyl]-4-hydroxy-2-oxo-3-quinolinecarboxamide | [no description available] | low | 0 | 0 | aromatic amide; quinolines | |
| N'-[(2-chlorophenyl)-oxomethyl]-1-ethyl-4-hydroxy-2-oxo-3-quinolinecarbohydrazide | [no description available] | low | 0 | 0 | aromatic amide; quinolines | |
| 4-hydroxy-1-methyl-N'-[(3-methylphenyl)-oxomethyl]-2-oxo-3-quinolinecarbohydrazide | [no description available] | low | 0 | 0 | aromatic amide; quinolines | |
| Bucharidine | [no description available] | low | 0 | 0 | quinolines | |
| 4-hydroxy-2-oxo-1-prop-2-enyl-N-(3-pyridinyl)-3-quinolinecarboxamide | [no description available] | low | 0 | 0 | aromatic amide; quinolines | |
| LSM-23565 | [no description available] | low | 0 | 0 | aromatic amide; quinolines | |
| l 701324 | [no description available] | low | 0 | 0 | quinolines | |
| 1-ethyl-4-hydroxy-2-oxo-N'-(1-oxoheptyl)-3-quinolinecarbohydrazide | [no description available] | low | 0 | 0 | aromatic amide; quinolines | |
| 2-[[[4-hydroxy-2-oxo-1-(phenylmethyl)-3-quinolinyl]-oxomethyl]amino]acetic acid | [no description available] | low | 0 | 0 | quinolines | |
| 1-ethyl-4-hydroxy-2-oxo-N'-(1-oxodecyl)-3-quinolinecarbohydrazide | [no description available] | low | 0 | 0 | aromatic amide; quinolines | |
| LSM-31922 | [no description available] | low | 0 | 0 | aromatic amide; quinolines | |
| 1-ethyl-4-hydroxy-2-oxo-N-(3-pyridinylmethyl)-3-quinolinecarboxamide | [no description available] | low | 0 | 0 | aromatic amide; quinolines | |
| N-(1H-benzimidazol-2-yl)-1-ethyl-4-hydroxy-2-oxo-3-quinolinecarboxamide | [no description available] | low | 0 | 0 | aromatic amide; quinolines | |
| N-[(3,4-dimethoxyphenyl)methyl]-4-hydroxy-2-oxo-1-propyl-3-quinolinecarboxamide | [no description available] | low | 0 | 0 | aromatic amide; quinolines | |
| 4-hydroxy-N-(2-methyl-4-oxo-3-quinazolinyl)-1-(2-methylpropyl)-2-oxo-5,6,7,8-tetrahydroquinoline-3-carboxamide | [no description available] | low | 0 | 0 | aromatic amide; quinolines | |
| 4-hydroxy-1-(2-methylpropyl)-2-oxo-N-[4-oxo-2-(phenylmethyl)-3-quinazolinyl]-5,6,7,8-tetrahydroquinoline-3-carboxamide | [no description available] | low | 0 | 0 | aromatic amide; quinolines | |
| 4-hydroxy-2-oxo-1-pentyl-N-(2-pyridinylmethyl)-3-quinolinecarboxamide | [no description available] | low | 0 | 0 | aromatic amide; quinolines | |
| N-[2-(4-chlorophenyl)ethyl]-4-hydroxy-2-oxo-1-propyl-3-quinolinecarboxamide | [no description available] | low | 0 | 0 | aromatic amide; quinolines | |
| 4-hydroxy-1,7,7-trimethyl-3-(2,4,6-trimethylphenyl)-6,8-dihydroquinoline-2,5-dione | [no description available] | low | 0 | 0 | quinolines | |
| sybr green i | [no description available] | low | 0 | 0 | benzothiazolium ion; cyanine dye; quinolines; tertiary amine | fluorescent dye |
| 9-(3,5-dimethoxyphenyl)-1-[4-(1-piperazinyl)-3-(trifluoromethyl)phenyl]-2-benzo[h][1,6]naphthyridinone | [no description available] | low | 0 | 0 | quinolines | |
| GSK1059615 | [no description available] | low | 0 | 0 | pyridines; quinolines; thiazolidinone | antineoplastic agent; EC 2.7.1.137 (phosphatidylinositol 3-kinase) inhibitor |